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ABSTRACT
Purpose: Assessment of health technologies in medical practice is an ongoing
process to provide clinicians and policymakers with information on the value of those
applications. This dissertation aims to add to the existing body of literature and fill the
gaps in prior studies by assessing two health technologies in Mayo Clinic Florida (MCF).
The first paper provides an assessment of patient portal adoption and activity during
hospitalization among cancer patients, and determines whether a portal application is
associated with selected indices of patient safety, utilization and satisfaction. The second
paper provides an assessment of a new approach in pain management after total knee
arthroplasty (TKA), a periarticular anesthetic injection (PAI), and compares patient
outcomes postoperatively among those who had this new pain management approach
versus the traditionally used approach of peripheral nerve blocks in a consecutive earlier
period. Methods: The first paper retrospectively reviewed all cancer inpatients admitted
in MCF between 2012-2014 (N=4,594), compared portal adopters (i.e., who registered
for a portal account) versus non-adopters, and compared inpatient portal activity among
active versus inactive users. The second paper retrospectively reviewed consecutive
patients who underwent primary unilateral TKA between March 1, 2013, and August 31,
2014 (N=511) and received FNB with SNB versus those who underwent TKA between
October 1, 2014 and March 31, 2016 (N=479) and received PAI. In addition to
descriptive statistics, postoperative outcomes, including pain scores, time to ambulation,
distance walked, in-hospital falls, length of stay, discharge disposition, satisfaction wit
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pain control, emergency visits within 14 days, readmissions within 30 days, revisions
within 90 days, and total cost of hospitalization and 90-day follow-up period, were
compared. SAS Version 9.4 was used for all analyses. Results: We found that 2352
(51.1%) were portal adopters, and of them, 632 (26.8%) were active inpatient users.
Adoption was influenced by predisposing and enabling factors, such as age, sex, race,
marital status, employment status, income, and type of health insurance. Active inpatient
use was similarly influenced by predisposing and enabling factors, such as age, race, and
marital status, in addition to factors related to need, such as being sicker, nonlocal and
admitted for medical treatment (P<0.05). In the second paper, we found that PAI had
better analgesic effect at 24 hours after surgery compared to FNB, but no differences at
48 hours. Patients who received PAI had earlier ambulation, longer walking distance,
shorter hospital stay, more discharges to home, better patient satisfaction with pain
control, and lower hospitalization cost. On average, each patient who had their pain
managed using PAI saved $3,539 on their TKA hospitalization cost. Conclusion: Based
on early evidence, cancer patients reached modest levels of portal adoption, with
increased adoption associated with predisposing and enabling determinants, and
increased inpatient use associated with need. In pain management after TKA, PAI was
superior in providing early postoperative pain relief, improved functional recovery, better
patient satisfaction with pain, and lower hospitalization cost compared to FNB with
single-shot SNB following TKA. Findings may provide insight for clinicians and
policymakers who are interested in health technology assessment and directing future
research efforts on the value of care.
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CHAPTER 1
INTRODUCTION

BACKGROUND
Medical practice has made rapid advances over the years through the adoption of
innovative clinical and information technologies which help to provide high-quality
health care. These technologies can result in more convenient, more-effective care
delivery and improved patient outcomes [1-3]. However, they are one of the primary
drivers of increased healthcare costs in the United States and society expects these new
advances to add benefits to their health outcomes [4, 5]. In fact, 17.4% of United States
GDP is currently consumed by the health care sector, and projected to reach about 19.6%
by 2024 [6]. The Congressional Budget Office concluded that “roughly half of the
increase in health care spending during the past several decades was associated with
expanded capabilities of medicine brought about by technological advances” [7].
Although healthcare technology continues to advance remarkably, its assessment
continues to lag significantly [8]. This assessment function requires collecting,
evaluating, and systematically reviewing all available evidence related to the use of the
technology under consideration. The Institute of Medicine reported that the cost of
healthcare assessment is less than 0.3% of the total amount spent on healthcare [9].
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The Office of Technology Assessment was established in 1972 and was funded by
the US Congress to undertake technology assessments to inform federal funding
decisions about emerging health and non-health technology [10]. In the 1990s, Health
Technology Assessment (HTA) was widely used and the assessments tended to focus on
efficacy, safety, cost-effectiveness, as well as patient-reported outcomes [10, 11]. HTA
also have the objective of providing a basis for health care that is more evidence-based in
order to be use scarce resources more efficiently, and improve health for patients and
the general population [12].
As defined by the United States Office for HTA, healthcare technologies include
drugs, devices, medical and surgical procedures as well as organizational and supportive
systems in which such care are provided [13]. In light of this definition, this dissertation
evaluates two healthcare technologies in Mayo Clinic Florida (MCF); an electronic
patient portal, and a new pain management approach used after total knee arthroplasty
(TKA). The document is presented in the following format: Chapter 1 provides basic
background information on the problem, rationale and the research questions related to
the two selected health applications; Chapter 2 provides an in depth review of relevant
research and the gap in literature; Chapter 3 provides the research methodology; Chapter
4 provides a manuscript related to patient portals; and Chapter 5 provides a manuscript
related to pain management after TKA. Results should provide insight for clinicians,
policymakers, research community and those interested in improving patient care through
technology.
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Study I: Patient Portal Adoption and Use by Hospitalized Cancer Patients: A
Retrospective Study of its Impact on Adverse Events, Utilization, and Patient
Satisfaction
STATEMENT OF THE PROBLEM
A Patient Portal tied to the provider electronic health record systems is a new
innovation in health information technology that is gaining popularity [14]. It grants
patients’ access to their own medical records, which is expected to transform how
healthcare is delivered [15, 16]. Since 1996, patients could legally access their clinical
records as part of the Health Insurance Portability and Accountability Act. However,
fees, illegible handwriting, or time delays were barriers that hindered information access
[17]. What sets the portal apart is the speed and flexibility with which patients can access
their updated health information securely at any time, to view information like recent
doctor visits, discharge summaries, medications, immunizations, allergies, and lab
results. More advanced portals enable patients to request prescription refills, schedule
appointments, exchange secure messaging with providers, and receive health educational
programs.
Most published studies about patient portals describe their use in the primary care
or outpatient settings [15, 18, 19]. Numerous research studies have shown that
information provided in the portal are effective in stimulating patients with chronic
conditions to monitor their care and promote their decision-making ability [20-22]. Yet,
few studies were found exploring portal use patterns among patients with Cancer, whom
in critical need for additional support for health information and care [23-26]. They
receive treatment through complex plans involving multiple care providers and settings
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such as surgery, radiation, and chemotherapy, which make information availability a
crucial part for them to reduce uncertainty and allow them to be responsible for making
important decisions.
RATIONALE FOR THE STUDY
Portals are considered a promising innovation to support greater patient
engagement. Patients who are engaged in their health have better adherence to safety
practices, better compliance and partnership with the healthcare team, and may
participate more in clinical trials and research [20, 27-29]. The Institute of Medicine
report “Crossing the Quality Chasm” suggested that enhancing the flow of information
among patients and medical providers would help reduce medical errors and improve the
quality of care [30]. A study by Weingart and colleagues in ambulatory oncology found
that active patient participation may reduce the risk of medical errors by providing
clinicians with current information about their medical histories, medications and drug
allergies [31]. In the inpatient setting, Weingart and colleagues surveyed 2025 patients
and found that active patient participation was strongly associated with favorable
judgments about hospital quality and reduced the risk of experiencing an adverse event
[32]. Prey et al 2014 conducted a systematic review of patient engagement in the
inpatient setting and concluded that research on inpatient engagement technologies has
been limited [33]. Therefore, patient portals represent a significant shift in the way that
health services are delivered and an opportunity to incorporate electronic health
technologies into clinical practice.
In 2009, the Health Information Technology for Economic and Clinical Health
(HITECH) Act incentivized clinicians to provide patients’ with electronic access to
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clinical records through the “meaningful use” incentive program administered by the
Centers for Medicare & Medicaid Services (CMS). Stage 1 meaningful use criteria
include providing patients with an electronic copy of their health information, whereas
stage 2 criteria were broadened to include enabling patients to view online, download,
and transmit information about a hospital admission. Recently, CMS published the final
rule for Stage 3, which focuses on the advanced use of the electronic portals to promote
health information exchange and improve patients’ outcomes [34]. Although providers
are subject to a financial penalty if the rules are not met, they are not incentivized if they
improve, such as by having a high rate of portal users, or providing advanced
functionalities that offer value to providers and patients. Thereby, as a policy implication,
policymakers should not only focus on the existence of electronic portals, but on the
effective use to achieve better engagement, health and satisfaction.
To this purpose, hospital leaders at MCF were interested to understand the pattern
of portal adoption and active use behaviors, specifically to the inpatient setting where
research is limited and the pattern in unknown. According to Karahanna et al., adoption
and continued use of an IT innovation represent different behavioral intentions [35].
Adoption is the initial usage (new behavior) of an innovation, while usage is the
subsequent continued use of an innovation after its adoption. In this study, Adoption is
the initial enrollment and signifies receptivity to the portal, while usage represents active
engagement, continued use after adoption. Therefore we distinguish between these two
behaviors and evaluate them separately.
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RESEARCH QUESTIONS:
The study will answer the following research questions:
1. What are the characteristics of patients who are portal adopters, non-adopters,
active inpatient users, and inactive inpatient users?
2. What factors influence portal adoption? What factors influence inpatient
portal use?
3. Compared to non-adopters, what is the association between: (a) active
inpatient use, and (b) inactive inpatient use, with adverse events, utilization
(14-days emergency visits, 30-days readmissions), and patient satisfaction
(self-management knowledge, overall satisfaction)?
Hypotheses:
1. I hypothesize that majority of portal adopters will be those who are young,
Caucasians, male, and married. We also hypothesize that inpatient users will be
those who are young, married, and sicker.
2. I hypothesize that predisposing factors (age, race, and marital status) will
influence portal adoption, and need factors will influence active inpatient portal
use.
3. I hypothesize that inpatient portal use will not be significantly associated with
reduced adverse events, emergency visits, and readmission, or improved patient
overall satisfaction. However, portal use may have a positive association with
self-management knowledge.
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Study II: Combined femoral and single-shot sciatic nerve block versus periarticular
anesthetic injection for pain management after total knee arthroplasty
STATEMENT OF THE PROBLEM
Pain is one of the main concerns of patients undergoing total knee arthroplasty
[36]. Over the last decade, different pain management techniques have become broadly
used as an alternative to opioids alone in pain management. The most common pain
control methods in TKA are general anesthesia, regional anesthesia using neuraxial
blockade (spinal or epidural anesthetic), and peripheral nerve blocks. However, general
and regional anesthesia may be inadequate as it causes extended recovery room stays,
postoperative nausea or vomiting, and associated added costs [37]. Epidural analgesia is
of proven benefit but is associated with side effects such as spinal headache, neurogenic
bladder,

hypotension,

respiratory

depression,

pulmonary

hypertension,

cardiac

decompensation, and a risk of spinal infection [38, 39]. Continuous infusion of opioids
and bupivacaine into the knee has provided good postoperative pain control but may be
associated with prolonged wound drainage [40]. Recent studies on continuous femoral
nerve blocks found it associated with higher incidence of muscle weakness and opioid
consumption, which led to delays in patient ambulation and more falls [41-43]. Recently,
the emergence of periarticular injections that provide effective control of postoperative
pain with fewer side effects has been one of the most important advances in orthopedic
surgery. In fact, adequate pain control using PAI in TKA is viewed as a revolution in the
management of postoperative pain, and a paramount to successful outcomes and patients’
satisfaction [44]. Previous studies have shown that PAI are easier to administer, provide
earlier mobilization, and are less costly [44-49].
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At MCF, a peripheral nerve block was the default pain control approach used in total
knee arthroplasty, using continuous femoral nerve block with single-shot sciatic nerve
block. As the introduction of periarticular injections become a new advancement, the
sister site, Mayo Clinic Arizona published results of a major randomized clinical trial
conducted between 2010 and 2013, comparing combined femoral and sciatic nerve block
with PAI as part of a multimodal pain protocol. Results found that PAI had equivalent
pain relief scores, but shorter lengths of stay, and fewer complications than those
associated with peripheral nerve blocks [50]. In September 2014, surgeons in Mayo
Clinic Florida (MCF) showed interest in pursuing a practice change, following the
Arizona model of care for pain management. They piloted the administration of PAI to a
couple of patients’ undergoing TKA, and preliminary results revealed superior
improvements in patients’ postoperative pain scores and recovery. Therefore, in October
2014, the orthopedic practice in MCF transitioned to primarily use PAI for pain
management after TKA. Since then, the change in practice from the prior to the later pain
management approach has not been rigorously evaluated in terms of analgesic efficacy,
functional recovery, length of stays, patient satisfaction and total cost. Also, differences
between these pain management approaches beyond the inpatient setting are unknown.
We documented post-discharge measures including emergency visits (14-days),
readmissions (30-days), revisions (90-days), and total cost incurred during the 90-day
period. While most published studies did report measures of pain relief and functional
recovery, to our knowledge, this is the first study to examine detailed cost per services
between PAI and FNB with single-shot SNB for primary TKA.
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RATIONALE FOR THE STUDY
There is a rapid increase in the number of TKA procedures performed annually
[51]. In 2005, 450,000 primary knee replacements were performed and projected to
increase almost eight-fold to 3.48 million in 2030, making joint replacements the most
common elective surgical procedures in the coming decades [52]. Because these
procedures are elective and expensive; Medicare paid approximately $3.2 billion in 2000
for hip and knee joint replacements, and because the prevalence of arthritis is expected to
grow substantially as the population ages, the demand for these procedures are likely to
increase [53]. Thus, healthcare services delivery must be planned effectively to meet
patients’ need and expectations for successful, safe and less painful procedures. Poorly
managed postoperative pain can prolongs the recovery and mobilization process, delays
discharge, reduces quality of life and increases unnecessary healthcare utilization such as
unscheduled readmissions [54]. Proper pain management allows patients’ to ambulate
faster, decrease their risk of having venous thromboembolism or acquiring hospital-based
infections due to longer hospital stays, and consequently reduce cost [55-58].
The IOM report “Across the Chasm: Six Aims for Changing the Health Care
System” outlined the most important aims to deliver better outcomes, where care should
be safe, effective, patient-centered, timely, efficient and equitable [30]. Fortunately,
advanced improvements in technology through devices and innovative techniques have
broadened the awareness in implementing best practice strategies for surgical and
anesthetic management. In fact, the choice of pain anesthetic technique has been shown
to play a significant role in promoting favorable surgical outcomes. Yet, few evaluation
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studies focused on evaluating TKA outcomes associated with using nerve blocks or
periarticular injections in light of these specific IOM aims.
The primary aim of this study was to compare patient outcomes postoperatively in
two exclusive, yet consecutive periods; a period where peripheral nerve blocks were used
versus the use of a periarticular anesthetic injection of ropivacaine, epinephrine,
ketorolac, and morphine, for pain management after TKA. Given the high frequency of
this procedure, results of this study may provide insight for clinicians to determine
efficient pain management approaches after TKA, and promote evidence-based clinical
policy for cost-effective pain management in orthopedic care. Results will also be useful
for patients to take an active role in their care and make more informed decisions
regarding their pain management approach.
RESEARCH QUESTIONS:
This study will answer the following research questions:
1. Are there significant differences in hospital outcomes of TKA patients who
received FNB versus PAI for pain management in terms of: (1) pain scores at 24
hours and at 48 hours, (2) time to first ambulation, (3) distance walked, (4) inhospital falls, (5) length of hospital stay, (6) discharge disposition, and (7) total
hospitalization cost?
2. Are there significant differences in post-discharge outcomes of TKA patients
who received FNB versus PAI for pain management in terms of: (1) patient
satisfaction, (2) emergency department visits within 14-days, (3) unplanned
readmissions within 30-days, (4) revisions within 90-days, and (5) total cost of
90-day post-discharge period?
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Hypotheses:
1. I hypothesize that patients’ who received PAI compared to nerve blocks will have
better hospital outcomes.
2. I also hypothesize that patients’ who received PAI will have lower TKA
hospitalization cost.
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CHAPTER 2
LITERATURE REVIEW

STUDY I: REVIEW OF LITERATURE
SIGNIFICANCE OF CANCER IN THE UNITED STATES
Cancer is a major public health problem in the United States (U.S.) and the
second-leading cause of death among Americans [59]. In 2012, an estimated 1,529,078
people were diagnosed with cancer in the U.S., and 582,607 people died of the disease
[60]. In 2013, there were an estimated 14,140,254 people living with cancer of any site
[61]. In 2016, it was estimated that there 1,685,210 new cases of cancer of any site will
emerge, with 595,690 estimated deaths [62]. According to cancer statistics, death rates
for cancer are higher among the middle-aged and elderly populations [61]. The percent of
cancer of any site deaths is highest among people aged 75-84 (26.9%). Overall cancer
age-adjusted incidence rates are higher among men than women (504.5 vs. 409.9 per
100,000) respectively. Among racial and ethnic groups, there are more new cases among
African American men (571.8 per 100,000) and white women (422.5 per 100,000) and
fewer new cases among Asian/Pacific Islanders of both men and women 317.3 and 296.7
per 100,000) respectively.
Among men, prostate (105.3 per 100,000), lung and bronchus (71.6 per 100,000),
colon or rectum (44.8 per 100,000), and urinary bladder (35.4 per 100,000) were the most
common cancers. Among women, breast (122.2 per 100,000), lung and bronchus (52.1
12

per 100,000), colon and rectum (34.1 per 100,000), and uterine corpus (25.7 per 100,000)
cancers occurred most frequently [62]. The Agency for Healthcare Research and Quality
(AHRQ) estimated that for 2012, the direct medical costs for cancer, including all health
care expenditures, were $87.5 billion, which is about 6.7% of total spending [63]. These
costs are more likely to increase due to the increased burden of the disease and aging of
the U.S. population. To meet these challenges, new approaches to healthcare delivery and
comprehensive population health management, education and awareness are required.
INFORMATION: A CRITICAL NEED FOR CRITICAL PATIENTS
Cancer patients usually face multiple active conditions, complex tests, procedures,
and treatments. These overwhelming conditions increase their need for information
support about their health status, and make them eager to better understand their
diagnosis, prognosis, and options for treatment [19, 64, 65]. Kowalski et al. 2014, found
that breast cancer patients who are younger, those receiving mastectomy, having health
insurance, not living with a partner or having a foreign native language reported higher
unmet information needs in hospitals [65]. Beckjord et al. 2008, studied a heterogeneous
sample of cancer patients and found that cancer survivors who were younger, had
comorbid health conditions or had worse physical or mental health had more information
needs [66]. In a population-based study, Nagler and colleagues reported that the rate of
information-seeking varied by tumor type, where patients with breast or prostate cancer
had higher information-seeking behavior than did patients with colorectal cancer, and the
differences were most pronounced in patients with early-stage disease [67]. Many
patients are increasingly using the Internet to acquire information, especially through
Web-based materials [68]. Online Cancer information seekers tend to be younger, more
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educated, and higher-income patients [69, 70]. Although the Internet is the most cited
source of cancer information, a survey involving patients receiving treatment for lung
cancer showed that only 16% actually sought information from the Internet [71]. This
study has also found that the Internet-derived information was perceived to be of a
similar quality to other non-clinical sources, suggesting that trust in the Internet is not
always the primary or only factor impacting patients to act on its information. According
to Shea–Budgell and colleagues, cancer patients believe that their health care provider is
the most trusted source of cancer information [72]. This finding is also supported by a
study focused on prostate cancer patients where they reported their doctor or other health
care providers as the trusted information source [73]. Among breast cancer patients, a
background survey showed that 86% of participants 'agreed' or 'strongly agreed' that
having reliable information approved from the hospital would make them feel more able
to make decisions about their treatment and disease [74]. Therefore, healthcare providers
have a responsibility to build better communication structure with their patients and meet
their information needs. Delivering appropriate information in a strong communication
and trust environment is a crucial enabling factor that supports patient-centered care,
which is a ‘fundamental paradigm shift’ in healthcare delivery according to the World
Health Organization [75]. The concept of patient-centeredness is specifically defined by
the Institute of Medicine (IOM) as “care that is respectful of and responsive to individual
patient preferences, needs, and values” [30]. In a patient-centered environment,
information exchange between providers and patients goes beyond just providing facts
and figures to tailoring information in response to an understanding of a patient’s
concerns, beliefs, and expectations. Evidence suggests that a patient-centered approach is
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strongly associated with satisfaction, better engagement and adherence to treatment, and
improved health and quality-of-life outcomes [76-78].
In today's healthcare system, information technology is the foundation of the
future. Unfortunately, most health care-related information technology investments have
been concentrated on the administrative and financial side, rather than on clinical care
(Reid, 2005). As a result, little progress has been made toward meeting the information
needs of patients and providers. However, current electronic patient portals have brought
new opportunities for efficient and high-quality patient centered care by providing
patients’ access to their own clinical information [15]. Since 1996, the Health Insurance
Portability and Accountability Act (HIPPA) guaranteed patients’ rights to review their
health records [79]. However, before the digital age, patients’ medical records were
paper-based, and patients’ demand for their own records had barriers due to cultural and
practical reasons or due to concerns by health care practitioners [80]. Also, illegible
handwriting, time delays and photocopying costs were other factors that hindered
information access [17]. Nowadays, the transition to electronic health records (EHR) has
become a significant factor in medical practice and healthcare systems. It has enhanced
the IOM principles of patient safety, timeliness, efficiency, and patient centeredness [30].
Many institutions are implementing electronic portals linked with EHR to fulfill patients
need for information and provide them with prompt access to their updated clinical
records. This information exchange will eventually transform the delivery of care on all
levels of the health care delivery system, the patient, the care team, and the overall health
care organization.
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PATIENT PORTAL USE AND IMPACT ON MEDICAL PRACTICE
Recently, patients do recognize the benefits of portals. In a nationwide survey
conducted in 2011, 70% of patients indicated interest in portal access if that was available
for them [81]. However, a recent systematic review demonstrated that patients’ interest
and ability to use patient portals is strongly influenced by personal factors such age,
ethnicity, education level, health literacy, and health status [20]. A cohort study at Kaiser
Permanente Georgia found that portal registration was more likely among whites, those
with Internet access at baseline, and those with more education [82]. A cross sectional
observational study by Goel and colleagues at an academic primary care practice found
that White patients were significantly more likely to enroll in patient portals than black,
Latino, and Asian patients (74% vs. 55%, 64%, 66%, respectively, p<0.05) [83]. A study
by Weppner and colleagues found that younger age, male sex, higher socioeconomic
status and greater illness rates were associated with earlier portal registration [84]. Group
Health Cooperative found that portal adopters were more likely to be with commercial
insurance and higher than expected clinical need [85]. Among portal registrants at the
Cleveland Clinic, whites were more likely than blacks to use the account after registering
for it [55]. Yamin and colleagues compared primary care patients who had activated their
portal account with those who had not, and found lower utilization among all racial
minorities [86]. In contrast, Phelps and colleagues observational study found a greater
portal use among those with more medical problems, particularly those with chronic
diseases [87]. A retrospective study conducted in New York found greater portal access
among those with private insurance [88]. The University of Pittsburgh evaluated the
characteristics of portal users and found higher access among those in poorer health, as

16

indicated by greater numbers of diagnoses and medications [89] . In a large oncology
cohort, greater healthcare need as expressed by disease burden and case complexity was
associated with portal use [24].
Studies indicate that information features enabled by patient portals are intended
to make patients more active in managing and monitoring their health. Thus, patients who
are armed with information about their condition make more informed choices about their
own health care and have greater satisfaction with treatment choices and quality of life
[17]. They also have better adherence to safety practices, better compliance and
partnership with the healthcare team, and possibly participate more in clinical trials and
further research [29].

Other studies found that engaging patients in their care will

improve their experience and enable them to take responsibility for their own care after
discharge [80, 90].
Several studies showed that access to electronic records in the outpatient setting
have increased their ability to self-manage chronic health conditions, medication tracking
and provided a safe way to renew their prescriptions [21, 91]. It has also increased the
ability to utilize appointment time more effectively, to prepare patients for appointments
by accessing results of previous tests and medications, and to interact efficiently with
clinicians for clarifying unclear information [16]. Despite potential advantages,
systematic reviews demonstrated that the most frequent obstacles reported on using
the portals were the complexity faced by those who lack technology experience,
frustration faced by complicated medical terminology, and anxiety and confusion when
information is viewed without concurrent clinical interpretation, which cause mutual
distress for patients and providers [24, 74, 92].
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However, most published studies about patient portals describe its use in the
primary care or ambulatory settings, with little experience reported on hospitalized
patients. In fact, patients need more information and engagement when they are admitted
to the hospital to reduce their feeling of isolation, uncertainty, and anxiousness [33, 93].
A controlled trial by O’Leary and colleagues provided the hospitalized intervention group
with a mobile portal, and found that the application was able to increase the patients’
knowledge of physician names and roles [94]. A qualitative study by Greysen and
colleagues evaluated the impact of providing tablet computers with an educational
module on patient safety and patient portal access to a pilot sample of 30 hospitalized
patients, and found it to be useful for increasing patients’ engagement [95]. Among
cancer patients, only a few studies have described the pattern of portal use and none was
found to evaluate associated outcomes. In a cohort of patients with hematologic
malignancies, 89% expressed interest in accessing electronic health records [90]. In
another study among breast cancer patients, 98% reported that having access to their
personal electronic health record would help them manage their care [74]. In a 10-months
study of 186 ambulatory patients with brain tumor, 60% had accessed a personal health
record at least one time during the study period, and access was significantly associated
with the reduction of their disease-related uncertainty [23]. A retrospective study among
heterogeneous cancer patients seen in a national cancer center, online electronic medical
record portal use was associated with younger age, white race, and an upper aerodigestive
malignancy diagnosis [24]. In this latter study, the majority of patient access occurred
during clinic hours, which suggests that access is more common when patients were in
the hospital.
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MAYO CLINIC PATIENT PORTAL
Mayo Clinic is a tertiary care non-profit medical practice that is recognized for
high-quality patient care. It is regarded as one of the world's greatest hospitals and ranked
No. 1 on the 2014–2015 U.S. News & World Report List of "Best Hospitals",
maintaining a position near the top for more than 20 years (Harder 2015). The Clinic was
first based in Rochester (Minnesota), and currently has major campuses in Jacksonville
(Florida), and Phoenix (Arizona), along with the Mayo Clinic Health System, which
consists of more than 70 hospitals. The institution has a three-part focus: patient care,
research, and education, which are represented by the shields in the Clinic logo. It also
has a history of investing in innovation by implementing projects that transform the
experience and delivery of healthcare through conducting continuous assessments and
improvements in the medical practice.
Innovative applications, particularly electronic patient portals were implemented
in Mayo Clinic to contribute to the patient-centeredness approach, aligning with the
primary statement of the organization that "the needs of the patient come first". MCF
contracted with Cerner solutions to implement the patient portal and integrated it with the
system-wide electronic medical record in 2010. When patients schedule an appointment
at MCF, they are invited to register for a portal account and are provided with
information on why and how to register. With each appointment reminder, patients
receive a re-invitation message to the portal. Portal invitations are also offered in all
outpatient waiting areas and displayed on electronic screens around the clinic. Once
registered, patients are able to access his or her account via a password-protected
encrypted Mayo Clinic website or mobile application on Android, Apple, or Amazon
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devices. The portal includes informational functions, such as viewing lab results, current
medications, allergies, and diagnostic reports from clinic visits and hospitalizations, and
administrative functions, such as paying bills, processing prescription refills, and
coordinating appointments. A Continuity of Care Document (CCD), a complete summary
of patient current health status and history, is also available to view, download, or
forward to physicians at other hospitals. Although the portal is designed for outpatients,
some functions are applicable to inpatient health information needs during the hospital
stay. Hospitalized patients have considerable time when they are not occupied with
diagnostic testing or other activities, which can be better utilized. For example, the portal
gives inpatients real-time access to lab results, admission notes, consultation reports, and
surgical notes, to view on their own time and between bedside rounds. This functionality
potentially facilitates patient communication and interaction with the healthcare team
during their stay, and empowers the patient to be more attentive toward errors in
documentation. In addition, the medication function provides patients with information
on the type and purpose of their medications, including in-hospital medication intake,
which could enable patients to ask questions, review for accuracy, or report medication
discrepancies. Before home discharge, a discharge summary and discharge instructions is
uploaded to the portal, giving patients time to review closely and ensure their
understanding of home self-management instructions. While the development of portal
functionality for inpatients is in early stages, the offered content may still help patients
become more activated and improve post-discharge care.
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STUDY II: REVIEW OF LITERATURE
BURDEN OF JOINT DISEASES AND THE NEED FOR TOTAL KNEE
ARTHROPLASTY
Arthritis is the most common cause of chronic knee pain and disability. Although
there are many types of arthritis, most knee pain is caused by just three types:
osteoarthritis, rheumatoid arthritis, and post-traumatic arthritis [96]. Total knee
arthroplasty (TKA), also called total knee replacement, is a common orthopedic operation
and an effective treatment for reducing severe arthritis pain and restoring the mobility of
patients [96]. Murphy et al. estimated that nearly half of all adults in the United States are
at risk of developing symptomatic knee osteoarthritis by 85 years of age [97], and
Weinstein et al. estimated that over half of the U.S. adults diagnosed with knee
osteoarthritis will undergo a TKA in some point in their lives [98]. The latter study also
estimated that the lifetime risk of primary total knee replacement from the age of 25 years
was 9.5% for women and 7.0% for men, increasing with age [98]. However, recent trends
are indicating an increase in prevalence over time and a shift to younger ages less than 65
years [52, 99]. Further studies found higher TKA procedure rates in women than in men,
in whites than in blacks, in those with higher incomes than in those who received
Medicaid supplementation, and in those living in the West North Central and Mountain
regions than other areas [100]. The rapid increase in TKA surgeries each year can be
attributed to the growth in life expectancy, aging population, surgical technical
advancements, and the increasing prevalence of population risk factors causing joint
problems [29, 52].
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PAIN MANAGEMENT AFTER TKA
Total knee arthroplasty have proven to be the most successful surgical
intervention aimed at improving mobility and quality of life among patients with arthritis
[101-103]. Yet, postoperative pain is one of the main concerns of patients undergoing
this procedure, and achieving satisfactory postsurgical pain control is a critical factor for
successful recovery [104-106]. Given the importance of the pain experience, the Joint
Commission and the Agency for Healthcare Quality and Research (AHRQ) introduced
standards for organizations to improve their care for patients with pain.
In the last few years, clinicians’ tended to focus more on pain management since
severe pain has profound implications on patients’ quality of life [107, 108].
Advancements in postoperative pain control headed toward multimodal pain management
approaches instead of using opioids alone [109]. Of these approaches, femoral nerve
block (FNB) which is a well-established analgesic to reduce pain post-TKA and seen as
the gold standard [110, 111]. However, many authors reported a number of disadvantages
including quadriceps weakness that delays recovery, increases risks of neurological
symptoms, falls, opioids consumption, and complications [43, 112, 113]. For this reason,
some clinicians combine sciatic nerve block (SNB) to a FNB, instead of using FNB
alone, in order to improve outcomes early after surgery [114-118]. Yet, the advantages of
SNB when combined with FNB continue to be debated in the literature [119, 120].
Compared with peripheral nerve block, periarticular anesthetic injections (PAI), a
concentrated multi drug injection, have been identified as a preferred alternative approach
for pain management after TKA [121]. Earlier clinical studies have been conducted to
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validate the efficacy and safety of different combinations of the PAI drug mixture, and
reported it to be easier to administer and have better patient outcomes [122-124].
Kirkness et al retrospectively compared patient outcomes who recieved PAI with
liposome bupivacaine versus those who received FNB, and found that more patients’ in
the PAI group walked on the day of surgery (22% versus 3%, p< 0.05), more likely to be
discharged within two days (50% versus 19%, p<0.001), and had shorter length of stay
(3.1 days versus 3.6 days, p<0.03) compared to the FNB group [125, 126]. Tfadhhol and
colleagues randomized clinical trial presented data suggesting that PAI with ropivacaine,
ketorolac, and epinephrine results in faster postoperative ambulation, as indicated by
being better able to walk more than 3 meters on the first postoperative day (POD) (74%
versus 19%. p<0.001) compared to FNB [127]. Affas and colleagues measured pain
during the first 24 hours after TKA, on a numeric rating scale (0–10), and found that pain
intensity at rest was marginally lower with infiltration (mean score: 1.6 versus 2.2) than
with FNB [128].
Still, other published studies found controversial conclusions. Wang et al metaanalysis found that single-injection FNB have better pain relief in the early postoperative
period compared with single and continuous periarticular multimodal drug injections,
with no significant difference seen in post-operative complications between the two
groups [129]. DeWeese et al conducted a retrospective comparison and found that other
injection mixtures such as those with containing fentanyl and bupivacaine resulted in
better pain relief than did continuous injection of the knee with bupivacaine [40].
Spanghel et al clinical trial used PAI mixture of ropivacaine, epinephrine, ketorolac, and
morphine and found patients who received it had shorter length of stay compared to those
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who received FNB (2.44 days versus 2.84 days; p=0.02), while no differences in mean
pain scores taken in three times points post-surgery were observed between the groups
[50].
Recent studies in the literature presented comparisons of direct hospital cost
associated with the two pain management approaches. In a single-site retrospective
cohort study of 268 patients, the mean adjusted total hospitalization cost per patient was
significantly lower among patients who received PAI with liposomal bupivacaine
compared to FNB ($8,758 versus $9,213, p=0.033) [126]. Similar conclusions were
found in a pre-post study among 125 TKA cases performed using either PAI with
liposomal bupivacaine or FNB, and found that the average hospitalization cost was
significantly lower with PAI compared to FNB ($26,472 versus $28,546; p< 0.001)
[130].
National calculations of aggregate annual costs for TKA hospital stay indicated
that it was the second most costly procedure at $11.3 billion after spinal fusion at $12.8
billion [131]. Therefore, it is suggested that effective pain management will influence
patients to regain mobility, facilitate recovery, decrease length of hospital stay and
consequently lower cost. However, consistent evidence on PAI as better alternative to
other pain management approaches is limited and research is needed to support its
efficacy [132-136].

Interestingly, healthcare payers and policymakers are currently

targeting total joint arthroplasty as an area for quality improvement and healthcare costsavings initiatives [137, 138]. In addition, because many surgical procedures have
migrated to the outpatient setting, stakeholders may be interested in pain control
approaches that enable easier and safer TKA that can be provided at lower cost.
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TKA IN MAYO CLINIC
In Mayo Clinic, TKA represents the most common elective hospital admission.
The Department of Orthopedics has enjoyed a phenomenal reputation for providing this
procedure successfully, leading to an extraordinary number of patients seeking care. In
fact, the first FDA-approved total joint arthroplasty in the U.S. was performed at Mayo
Clinic 45 years ago (first total hip arthroplasty - March 10, 1969 by Dr. Mark Coventry
and team at Rochester Methodist Hospital).

Since then, Mayo orthopedic care has

routinely ranked among the very best in the country. Today, Mayo destination sites in
Rochester, Arizona, and Florida perform more than 6000 TKA per year, making it one of
the largest practices in the U.S. As such, this service line justifies the work and attention
to better delineate objective measurement of quality, cost, and the value of provided care.
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CHAPTER 3
METHODOLOGY

STUDY I METHODS
STUDY DESIGN AND SAMPLE:
This was a retrospective review of patients satisfying the following criteria: (1)
adults (≥18 years old), (2) had cancer as a primary or secondary diagnosis at time of
hospitalization identified through the International Classification of Disease (ICD-9)
codes, and (3) admitted to MCF between August 1, 2012 and July 31, 2014 (N=4594).
Per the unified theory of acceptance of use of technology (UTAUT), user acceptance and
intention to use of information technology is subsequent by usage behavior [139]. Thus,
we included the first hospitalization where a portal account had been established prior to
admission to examine consequent inpatient use. If the patient had not established a portal
account prior to any admission, then the first hospitalization in the study period was
selected. Patients who had a portal account prior to admission were defined as
“adopters”, and those without a portal account were “non-adopters”. Among adopters,
inpatients who logged in their portal during the hospital stay were “active inpatient users”
and those who never logged in were referred to as “inactive inpatient users”. The study
cohorts and sample size are presented in Figure 3.1.
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Patient Portal in MCF
(Aug 2012-July 2014)

Non-Adpoters
(N=2242)

Adopters (N=2352)

Active Inpatient Users
(N=632)

Inactive Inpatient Users
(N=1720)

Figure 3.1 Study I Cohorts and Sample Size
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CONCEPTUAL MODEL:
A study theoretical model was developed based on Andersen’s model of
Healthcare Utilization (Figure 3.2). Andersen’s model was initially developed to
understand health services use and later revised to include consumer satisfaction and
dimensions of health status [140, 141]. Shortly after the model was developed, health
services use was portrayed as a health behavior influenced by multiple factors [142].
According to the World Health Organization (WHO), health behavior was defined as
“any activity undertaken by an individual, regardless of actual or perceived health status,
for the purpose of promoting, protecting or maintaining health, whether or not such
behavior is objectively effective towards that end” [143]. Because the portal is a tool to
maintain and promote health, we considered portal adoption and inpatient use as health
behaviors that could be studied using Andersen’s model. We assumed that all study
participants had a common environmental context, as all patients in MCF received their
care in the same structure. Patient characteristics were classified into predisposing,
enabling, and need factors as described in the model below.

STUDY MEASURES:
A. Predisposing Factors:
This included demographic variables such as gender (male as the reference
group), age (categorized as: 18-44, 45-54, 55-64, 65-74 “reference”, 75-84, and 85 or
above), and race (categorized as Caucasian “reference”, African American, and Other
group that includes Asian, Native Hawaiian or other Pacific Islander, American Indian,
and those with more than one race.
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Environment

Patient Factors

Portal Behavior

Predisposing1

Adoption

Enabling2

Active
Inpatient Use

MCF

Outcomes

(1) Patient Safety:
Had an adverse event
(2) Post-discharge care
Utilization:
- Emergency visit within 14 days
- Unplanned readmission within
30 days
(3) Patient Satisfaction:
- Self-health management
knowledge
- Overall hospital experience

Need3

Figure 3.2 Study I Theoretical Model
1 Predisposing factors: age, sex, and race.
2 Enabling factors: marital status, employment status, health insurance type, and income.
3 Need factors: geographic area of residence, comorbidities, and frequency of
hospitalizations. Additional need factors related to the admission: MSDRG type and
APRDRG disease severity weight.
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B. Enabling Factors:
This included social and financial factors, including marital status (broken into
divorced, married “reference”, single and widowed), employment status (broken into
disabled, employed “reference”, not-employed, retired, and unknown, where patients did
not report their employment in their registration forms). Initial analysis showed a large
segment of the study sample with unknown employment, and that is why it was included
and analyzed as a category. Geographical area of residence was broken into international,
national, regional (North East Florida and South Georgia), and local (Jacksonville area),
where “local” was used as the referent level.
Financial factors included health insurance type (broken into governmental (i.e.,
Medicare & Medicaid) “reference”, and non-governmental insurance (i.e., commercial
insurance and self-payers). Self-payers were less than 3% of the sample, thus was
included as a separate category. We reported whether patients had a median household
income less than Florida’s state median income ($48,277) based on their residential ZIP
code, a surrogate for socio-economic status. The median household income was extracted
from the most recently available (2006-2010) American Community Survey (ACS),
matched to our sample at the ZIP code level [144]. We were unable to match 1% of the
sample with ACS, either due to being an international patient or no data was available in
ACS for the patient ZIP code, thus, patients were assigned the average median income for
the study sample.
C. Need Factors:
This category included the frequency of hospitalizations in the study period as a
continuous variable and number of comorbidities categorized in three groups: no
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comorbidities “reference”, one to two, and three or more. Comorbidities were counted by
the presence of any Deyo-Charlson diseases “yes/no” 12 months prior to the encounter.
Deyo-Charlson is a validated measure to categorize comorbidities of patients based on
the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9CM) diagnosis codes found in administrative data [145]. The original Index was
developed with 19 categories, but has been modified to 17 categories, which are
myocardial infarction, congestive heart failure, peripheral vascular disease, dementia,
ulcer, cerebrovascular disease, chronic pulmonary disease, mild liver disease, metastatic
solid tumor, tumor without metastasis, diabetes, diabetes with organ damage, hemiplegia,
moderate

or

severe renal disease,

moderate

or

severe liver disease,

aids,

and

rheumatologic disease. We excluded the count of metastatic solid tumor and tumor
without metastasis categories as all patients included in the study do have tumor, and our
interest was to count other existing diseases.
Additional need determinants related to the hospital admission were documented
including admission service (medical “reference” versus surgical) based on the Medicare
Severity-Diagnosis Related Group (MSDRG) codes. We also documented disease
severity weight as measured by “All Patient Refined Diagnostic Related Groups”
(APRDRG) classification system, which classifies patients according to their reason of
admission, severity of illness and risk of mortality [146].
D. Outcomes:
1. Emergency visits within 14-days after discharge obtained from hospital internal
records. (categorical: yes/no)
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2. All cause unplanned readmission within 30-days after discharge obtained from
hospital internal records. (categorical: yes/no)
3. Patient Satisfaction, obtained from the Hospital Consumer Assessment of Healthcare
Providers and Systems (HCAHPS) survey[147]. HCAHPS is a national standard
validated survey to measure patients' perspectives on hospital care developed by the
Centers for Medicare & Medicaid Services (CMS) and the Agency for Healthcare
Research and Quality (AHRQ)[148]. HCAHPS in Mayo Clinic was distributed by
mail to a random sample of patients between 48 hours and 6 weeks after discharge.
The survey is 32 questions in length. However, initial analysis showed low received
responses and therefore we could not include all survey questions, and selected the
relevant items with highest response. We also could not calculate the response rate as
MCF contracted with an external company “Cerner” for data collection, and the
agreement included only returned surveys, which was hence a study limitation.
We measured patient self-health management knowledge with two questions:
1. HCAHPS 24: When I left the hospital, I had a good understanding of the things I was
responsible for in managing my health,
2. HCAHPS 25: When I left the hospital, I clearly understood the purpose for taking
each of my medication,
and measured overall hospital satisfaction with one question:
3. HCAHPS 21: Using any number from 0 to 10, where 0 is the worst hospital possible
and 10 is the best hospital possible, what number would you use to rate this hospital
during your stay.
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Responses were transformed and averaged, resulting in a 0 to 100 linear-scaled
score as follows: ("Strongly Disagree" = 0; "Disagree" = 33.3; "Agree" = 66.7; and
"Strongly Agree" = 100) for HCAHPS questions 24 and 25, and (Overall Rating "0" = 0;
Overall Rating "1" = 10; Overall Rating "2" = 20; …; Overall Rating "10" = 100) for
HCAHPS question 21.
DATA ACQUISITION:
Data was extracted from the EHR and the Decision Support System (DSS). These
two databases were matched to obtain information on patient characteristics and
outcomes for the selected hospitalization. HCAHPS patient experience data were
obtained from the quality management department.
DATA ANALYSIS:
We described the characteristics of oncology patients according to their portal
adoption and inpatient activity behaviors and examined differences between groups using
Pearson χ2 and Wilcoxon nonparametric tests. Univariate and multivariable logistic
regression models were used to test the association between patient characteristics, and
adoption behaviors separately adjusting for patient characteristics. Multivariate logistic
and linear regression models were used to examine the association between outcomes and
portal behaviors. Statistical analyses were performed using SAS Version 9.4 (SAS
Institute Inc., Cary, NC, USA), and significance was defined as P<0.05. Detailed analysis
plan is shown in Table 2.
BUDGET:
None
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ETHICAL CONSIDERATIONS:
The study proposal was approved by the Institutional Review Board (IRB) in
Mayo Clinic (# 14-006039). All extracted data were stored on a password-protected
server known only to the researcher.
CONFLICT OF INTEREST:
None

STUDY II: METHODS
STUDY DESIGN AND SAMPLE:
This was a retrospective chart review of patients who were at least 18 years of age
and received a primary unilateral total knee arthroplasty at Mayo Clinic Florida.
International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM)
and International Classification of Diseases, 10th Revision, Clinical Modification (ICD10-CM) procedure codes for total knee arthroplasty were used to extract eligible patients,
as the practice transitioned to use the later coding system in December 2014. A total of
1158 TKA patients were screened to obtain 990 eligible patients for the study. Figure 3.3
illustrates the process of screening patients for eligibility. We compared patients cohorts
who received FNB combined with single-shot SNB for pain control after TKA between
March 1, 2013 and August 31 2014 versus patients who received PAI between October 1,
2014 and March 31, 2016.
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Table 3.1 Detailed analysis plan for Study I
Objectives

Comparison groups

Variables

Adopters vs. non-adopters
Question #1
Patient Characteristics

Among adopters:
Active vs. inactive inpatient
users

Predisposing, enabling, and
need factors

Type of analysis
1. Descriptive analyses including
frequencies, means and standard
deviations, and percentages as
appropriate.
2. Examine differences between
groups using Pearson χ2 and
Wilcoxon nonparametric test.

Question #2
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Predictors for adoption

Dependent:
Portal Adopter: Yes/no

Question #2
Predictors for active
inpatient use

Logistic regression model for each
dependent variable

Dependent:
Active inpatient user: Yes/no

Dependent: (5 separate models)
1. Adverse event (yes/no)
2. Emergency visit (yes/no)
Association of inpatient 3. Readmission (yes/no)
4. Self-management knowledge
portal behaviors and
score
outcomes
5. Overall satisfaction score
Question #3

Adjusting for patient
predisposing, enabling,
and need factors

Portal behavior:
nonadopter (reference),
active inpatient user,
inactive inpatient user
adjusting for age and disease
severity (APRDRG weight)

Logistic regression for adverse
events, emergency visits, and
readmissions. Linear regression for
self-health management knowledge
and overall hospital experience
scores.

Total Knee Replacement cases assessed for eligibility
(n=1158)
Excluded (n=168)
1. Bilateral and Revision surgeries, (n=11)
2. Patients with prior TKA or partial knee replacements, (n=104)
3. Had TKA procedure during the change period (Sep 2014), (n=24)
4. Had overnight TKA; LOS<24hors, (n=2)
5. American Society of Anesthesiologists score > III, (n=6)
6. Patients who did not receive FNB or PAI, (n=21)

Cases met inclusion criteria
(n=990)

Index Hospitalization
Received FNB combined with SNB
(n=511)

Received PAI
(n=479)

90-day Follow-up*
Excluded (n=248)
1. Had major elective surgery
readmission, (n=27)
2. Patients not living locally, (n=235)
3. Outlier cost > $20,000, (n=6)

Excluded (n=201)
1. Had major elective
surgery readmission,
(n=24)
2. Patients not living
locally, (n=190)
3. Outlier cost > $20,000,
(n=5)

90-day Cost Analysis
Analyzed (n=263)

Analyzed (n=278)

Figure 3.3 Study II Flow diagram of patients’ exclusions and eligibility
*Exclusion criteria in the 90-day follow up period are not mutually exclusive.
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DESCRIPTION OF THE PAIN MANAGEMENT APPROACHES
Identical surgical procedure, implants, and same surgery team with similar patient
distribution for each surgeon, performed TKA in the two periods, minimizing the chance
for variability and provider factors. For patients who received FNB combined with
single-shot SNB, the same anesthesiologist performed the anesthesia for all cases, using a
pre-procedure sedation with 0.5 mg midazolam and fentanyl. After that, patients had an
indwelling continuous femoral catheter supplemented with a single-shot SNB in cases
that did not have significant valgus deformity or radiculopathy. Ultrasound imaging aids
the anesthesiologist in placing the needle in exactly the right location, under surgical
aseptic conditions. For patients who received PAI, the anesthetic mixture was
administered based on weight, as previously used by Spanghel and colleagues in Mayo
Clinic Arizona and presented in Table 3.2 [50]. PAI was administered by the same
surgeon, minimizing the potential for confounding effects on injection technique. The
injection was administered by 18 gauge needle as multiple boluses into the periarticular
tissue surrounding the knee joint prior to site closure, with no additional infusion or
injections after site closure. 30cc was placed in the posterior capsule and the rest was
throughout the anterior knee periarticular tissues and subcutaneous tissues. Detailed
description of the procedure is explained elsewhere [50]. The efficacy and safety of
several different combinations of the mixture have been established in earlier studies
[123, 124, 149].The postoperative pain control was the same for both groups and
included the use of analgesia such as morphine, acetaminophen, celecoxib, tramadol, and
narcotics, administered via oral or intravenous means as necessary.
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Table 3.2 Periarticular injection concentrations:
Weight (kg)

50-74.9

77-99.9

100-125

Ropivacaine

200 mg

300 mg

400 mg

Epinephrine

100 mg

200 mg

300 mg

Ketorolac

30 mg

30 mg

30 mg

Morphine sulphate

5 mg

5 mg

5 mg

Normal saline added to bring volume to 120 mL.
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CONCEPTUAL MODEL:
The conceptual model was developed based on Donabedian model of structure,
process and outcomes (Figure 3.4).

Structure

Same:
• Hospital
environment
• Surgery team,
supplies, and
equipment
• Primary anesthesia
protocol
• Post-surgery pain
medications
protocol

Process

September 2014
Transition in pain
control approach
during surgery
from FNB/SNB (ie,
Combined femoral
and single-shot sciatic
nerve block) to PAI
(ie, Periarticular
Anesthetic Injections
of ropivacaine,
epinephrine,
ketorolac, and
morphine

Figure 3.4 Study II Theoretical Model
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Outcome

1. Hospital measures
• Pain scores
• Mobility (distance
walked, time to first
ambulation)
• In-hospital falls
• Length of stay
• Discharge disposition
2. Postdischarge
measures:
• Patient satisfaction
(pain, overall)
• Emergency visits – 14
days
• Readmissions – 30
days
• Revisions – 90 days
3. Total cost
• Index hospitalization
• 90-day period

Our assessed outcomes are also aligned with IOM aims of healthcare quality [30].
Please refer to Figure 3.5 that demonstrates how our outcomes are related to those aims,
putting the issue of patient safety and quality on the radar screen of clinicians and
policymakers.

IOM, 2001 Aims of Healthcare Quality

Timely

Efficient

Postdischarge
Measures

Hospital
Measures

Length of hospital stay

Effective

Safe

Discharge
disposition

In-hospital
falls

Patient
Centered

Equitable

Functional recovery (time to first ambulation,
and distance walked)
Pain scores

Cost

Patient Satisfaction

Emergency department visits, readmissions, and revisions

Figure 3.5 Study II outcomes and IOM aims of healthcare quality
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STUDY MEASURES:
A. Patients’ Characteristics:
Age was reported continuously and broken-down to categories of (<54), (55-64),
(65-74), and (75 and above) to give a detailed description of the sample, where (55-64)
group was used as the referent level as it was the majority of our sample. Body Mass
Index (BMI) was categorized into normal (18.5-24.9), overweight (25.0-29.9), and obese
(30.0 and above), based on the BMI classification by CDC. Sex was broken into male and
female, where the male group was used as the referent level. Race was broken into
Caucasian “reference”, African American, and Other group that included Asian, Native
Hawaiian or other Pacific Islander, American Indian, and those with more than one race.
Marital status variable was broken into either married “reference” or divorced, single or
widowed. Employment status was broken into employed “reference”, retired, or notemployed and disabled. Health insurance type was categorized in governmental
“reference” and non-governmental insurance groups. Tobacco smoking status was
categorized in ever smoker (i.e., current of former smoker) versus never smokers, where
the later was the referent group.
Physical status was measured using the American Society of Anesthesiologists
(ASA) classification system, a validated measure for preoperative measurement to
identify patients with an increased risk of death or surgical complications, and rank them
in groups based on disease severity [102]. The classification adopts a five-category
classification system ranging from I to IV, but the study will only use; class I: normal
healthy patient, class II: patient with mild systemic disease (with no functional
limitation), and class III: patient with severe systemic disease (with some functional
limitation). Comorbid conditions present during the 12 months prior the index
41

hospitalization was collected based on diseases included in the Deyo-Charlson index, a
validated measure of comorbidity [145], and categorized in three groups: no
comorbidities “reference”, one to two, and three or more. We counted additional diseases
that are not included in Charlson index, and known to be of the most common
comorbidities associated with patient outcomes in orthopedic care. These include
congestive heart failure,

cerebrovascular

disease,

peripheral

vascular disease,

chronic pulmonary disease, and anxiety or depression [51, 57, 102, 150]. The top
comorbidities among patients were reported separately in the descriptive analysis.
B. Outcomes:
All study outcomes were measured postoperatively.
1. Analgesic effect (continuous): measured by pain scores using a numerical rating scale
ranging from 0 (No pain) to 10 (Worst possible pain) and reported for the 0-24 hours
and 24-48 hours interval after surgery.
2. Functional recovery (continuous): measured by time from end of surgery to first
walk, and by distance walked each day as documented in physical therapy (PT) notes.
We then reported cumulative distance walked in the first three PT sessions, which
was the minimum sessions received by all patients.
3. Length of hospital stay (continuous): from end of surgery to discharge.
4. In-hospital falls (categorical variable: yes/no).
5. Discharge disposition (categorical): whether a patient was discharged to home/ home
care, or to other facility including skilled nursing facility (SNF), hospice, or
rehabilitation center.
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6. Patients’ satisfaction (continuous): measured by the validated Hospital Consumer
Assessment of Healthcare Providers and Systems (HCAHPS) survey, distributed to a
random sample of discharged patients ranging between two days and six weeks after
discharge [147, 148]. Two questions were selected to assess satisfaction with pain: (1)
“How often was your pain well controlled?”, and (2) “How often did the hospital staff
do everything they could to help you with your pain?”. One question assessed the
overall satisfaction with hospital experience: “Using any number from 0 to 10, where
0 is the worst hospital possible and 10 is the best hospital possible, what number
would you use to rate this hospital during your stay”.
7. Cost (continuous), using standardized, inflation adjusted costs for services and
procedures billed during the index hospitalization and 90-day follow up period.
8. Emergency visits within 14 days after discharge (categorical: yes/no).
9. Unplanned readmission for any cause, 30 days after discharge (categorical: yes/no).
10. Surgery revision within 90 days after discharge (categorical: yes/no), which includes
prosthesis loosening, wear, and/or osteolysis, instability, infection, bone or prosthesis
fracture.
DATA ACQUISITION:
Patients’ cohorts were identified from the Decision Support System (DSS), and
then subsequent demographic and clinical data were matched with data in the EHR. Inhospital falls were obtained from the quality management department. Patient satisfaction
data were obtained from the office of patient experience. Responses to satisfaction items
were transformed and averaged (never=0, sometimes= 33.3, usually=66.6, and always=
100), resulting in a 0 to 100 linear-scaled score. Cost data were obtained from the
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institution cost data warehouse [151],

which applied Medicare reimbursement to

professional services, multiplied service line hospital charges by Medicare cost report
cost-to-charge ratios, and adjusted for inflation with the gross domestic product implicit
price deflator to create 2016 standardized costs. Cost was reported separately for the
index hospitalization and 90-day follow-up period excluding hospitalization, using
Berenson-Eggers Type of Service (BETOS) and Uniform Billing-04 (UB04) codes to
classify the line item data. A further grouping of cost categories was carried out to create
cost components by

type of service: analgesic approach (i.e., nerve block and the

periarticular supplies and medications); room and board (i.e., observation and intensive
care unit stay); operating and recovery room occupation; orthopedic procedure; physical
therapy; pain medications; laboratory and pathology; supplies; and other costs including
blood transfusion, other medications/intravenous fluids, and miscellaneous. Follow-up
cost data did not include medications obtained from outpatient pharmacies. Other
outcomes such as emergency visits, readmissions, and revisions were collected and
obtained from the EHR.
DATA ANALYSIS:
Analyses utilized SAS version 9.4 (SAS Institute, Cary, NC).

Insignificant

differences were found in the majority of patient characteristics between the groups. As
providers were the same surgery team during the study period, there was no risk of
learning affect among providers in the two cohorts. The distribution of cases per provider
was tested to ensure consistency, and both surgeons had the same volume of cases.
Secular trend of specific outcomes (pain scores at 24 and 48 hours, time to first
ambulation, distance walked in the first 3 PT sessions, postoperative LOS) were tested
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per cohort using interrupted time analysis, and the consistency of outcomes was ensured
to be the same within each cohort (P>0.05). Thus, our analysis was focused on comparing
between the outcomes of patients who had FNB with SNB (group 1) versus PAI (group
2). Our sample had a non-normal distribution; thus, we performed univariate chi-squared
test for categorical variables, an independent Wilcoxon signed-rank test for mean
comparison among continuous variables, with Fisher's exact test for cell counts <40. Cost
variables were presented as mean and median cost per patient including SDs and
interquartile ranges. We used repeated generalized linear regression models to determine
if receiving PAI was a predictor for (1) pain scores at 24 hours, (2) pain scores at 48
hours, (3) distance walked, (4) postoperative LOS, and (5) total cost of index
hospitalization. Independent variables in the regression analysis included age, sex, race,
marital status, BMI, ASA class, and comorbidities. In

modelling

the

index

hospitalization total cost, we used log-transformed costs. For the 90-day follow up
period, we excluded selected patient groups (i.e., patients with costs exceeding $20,000
that was not related to TKA, non-local patients as they were less likely to follow up in the
Mayo Clinic, and patients who were electively readmitted for major surgeries).
BUDGET: None
ETHICAL CONSIDERATIONS:
This study was approved by the Mayo Clinic Institutional Review Board. All
extracted data were accessed using techniques that are in compliance with the Health
Insurance Portability and Accountability Act of 1996 (HIPAA), and stored on a
password-protected server known only to the researcher.
CONFLICT OF INTEREST: None
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Table 3.3 Detailed analysis plan for Study II
Objectives

Comparison groups

Variables

1. Descriptive analyses including
frequencies, means and standard
deviations, and percentages as
appropriate.

Question #0
Patient
Characteristics

FNB/SNB vs. PAI
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Differences
between groups in
hospital outcomes

Question #2

Secondary
analysis

Patient demographic and clinical
characteristics

FNB/SNB vs. PAI

Question #1

Differences
between groups in
postdischarge
outcomes

Type of analysis

FNB/SNB vs. PAI

Dependent variables (analyzed
separately): pain scores at 24 hours,
at 48 hours, time to first ambulation,
distance walked, post-operative LOS,
and total cost of the hospitalization

(1)
(2)
(3)
(4)
(5)
(6)
(7)

pain scores at 24hr and at 48hr,
time to first ambulation,
distance walked in first 3 PT sessions,
in-hospital falls,
length of hospital stay,
discharge disposition, and
total hospitalization cost

(1) patient satisfaction,
(2) emergency department visits /14days,
(3) unplanned readmissions/ 30days,
(4) revisions/ 90 days, and
(5) total cost of follow-up during the 90
day period

Independent variable:
PAI (yes/no*)
*no (i.e., FNB/SNB)

2. Examine differences between
groups using Pearson χ2 and
Wilcoxon nonparametric test.

1. Examine differences between
groups using Pearson χ2 and
Wilcoxon nonparametric test.
2. Graphic comparison for cost per
service using bar graph.

Examine differences between groups
using Pearson χ2 and Wilcoxon
nonparametric test.

Several linear regression models,
adjusting for age, gender, race,
marital status, BMI, ASA and
comorbidities.

CHAPTER 4
Manuscript I Patient Portal Adoption and Use by Hospitalized Cancer
Patients: A Retrospective Study of its Impact on Adverse Events,
Utilization, and Patient Satisfaction
ABSTRACT
Background: Portal use has been studied among outpatients, but its utility and impact on
inpatients is unclear. This study describes portal adoption and use among hospitalized
cancer patients and investigates associations with selected safety, utilization, and
satisfaction measures.
Methods: A retrospective review of 4,594 adult hospitalized cancer patients was
conducted between 2012 and 2014 at Mayo Clinic in Jacksonville, Florida, comparing
portal adopters, who registered for a portal account prior to hospitalization, with
nonadopters. Adopters were classified by their portal activity during hospitalization as
active or inactive inpatient users. Univariate and several logistic and linear regression
models were used for analysis.
Results: Of total patients, 2,352 (51.2%) were portal adopters, and of them, 632 (26.8%)
were active inpatient users. Portal adoption was associated with patients who were young,
female, married, with higher income, and had more frequent hospitalizations (P<.05).
Active inpatient use was associated with patients who were young, married, nonlocals,
with higher disease severity, and were hospitalized for medical treatment (P<.05).
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In univariate analyses, self-management knowledge scores were higher among adopters
vs nonadopters (84.3 and 80.0, respectively; P=.01) and among active vs inactive
inpatient users (87.0 and 83.3, respectively; P=.04). In regression models adjusted for
age and disease severity, the association between portal behaviors and majority of
measures were not significant (P>.05).
Conclusions: Over half of our cancer inpatients adopted a portal prior to hospitalization,
with increased adoption associated with predisposing and enabling determinants (eg: age,
sex, marital status, income), and increased inpatient use associated with need (eg:
nonlocal residence and disease severity). Additional research and greater effort to expand
the portal functionality is needed to impact inpatient outcomes.
Keywords: adverse events; cancer; hospitalization; portal; satisfaction; utilization.

INTRODUCTION
Two decades ago, the National Academy of Medicine (formerly the Institute of
Medicine recommended implementation of electronic health records to improve quality
of care in the United States [30]. Since then, health information technologies have been
rapidly adopted, with a focus on providers rather than patients. In 1996, the Health
Insurance Portability and Accountability Act legally allowed patients to access their own
clinical records. However, record retrieval fees, illegible handwriting, and time delays
hindered accessibility [17]. An additional challenge is the fragmented health system with
many independently owned and operated health care service locations [19, 152, 153]. An
integrated information system that aggregates and offers updated health information to
patients through a single access point was needed. In 2009, the Health Information
Technology for Economic and Clinical Health Act incentivized clinicians to provide
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patients with electronic access to clinical records through meaningful use rules,
administered by the Centers for Medicare & Medicaid Services [34]. This incentive
program remains the principal driver of patient portal development by funding nearly $30
billion in provider incentives to encourage appropriate use [24, 154]. Investigations
where information access was offered via patient portals in the outpatient settings showed
encouraging positive effects in patient satisfaction and self-management behaviors [14,
15, 18, 19, 21, 27, 80, 85, 155-157]. However, providing patients access to information is
important not only in home and outpatient settings, but also when patients are
hospitalized [93].
When patients are able to see their own health information during the hospital
stay, they become more informed, empowered to ask questions, and gain ownership of
their health care [158, 159]. Despite daily bedside rounds, important patient informational
needs may not be met due to the cost of reviewing tailored information with each patient
individually [160]. Thus, the portal technology may provide opportunity for inpatients to
meet informational needs, facilitate awareness, and improve understanding of their care
during hospitalization and after discharge [17, 161]. Meeting informational needs could
reduce uncertainties surrounding the care process, reduce information asymmetry
between patients and providers, promote shared decision-making, and increase patient
self-management and adherence to care [33, 162].
Unfortunately, assessments of patient portal use among hospitalized cancer
patients are limited [23-25, 64, 74, 90]. For many patients, the hospital is a challenging
and intimidating setting, compounded by unmet information needs and limited patient
engagement [162, 163]. The rapid dynamic and pace of clinical care, changing medical
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teams, reliance on verbal communication, and absence of an established relationship with
the care providers further challenge patients’ effective participation in their own care
[164, 165]. Additional affective and emotional challenges are faced by inpatients with
cancer due to the nature of their disease, frequently uncertain outcomes of treatments, and
the need to understand their multiple active conditions to make treatment decisions [65,
66]. In a study of breast cancer patients, those who desired an active role in treatment
decision making also desired detailed information of their diagnosis, treatment
procedures, and alternatives [166]. Similar information needs were vital to gynecologic
and colorectal cancer patients who felt that information about the likelihood of cure,
spread of disease, and treatment options were priorities for decision making [167].
Providing clinical information through patient portals may have the potential to transform
the patient-physician relationship and help patients to become active in their disease
management [91]. Recent documentation on hospital-based patient portals is encouraging
[26, 94, 168, 169]. Creber et al published a protocol for developing a personalized
inpatient portal at an urban academic medical center to improve cardiology inpatients
engagement [17]. Greysen et al conducted pilot interviews showing patients’ enthusiasm
for a tablet application that provides health information during their inpatient stay [95].
Vawdrey et al assessed the patient-perceived efficacy of tablets to improve cardiothoracic
surgery patients’ engagement in care, showing a favorable response regarding usability of
the application [93]. Several other studies assessed the feasibility of web-based
applications to increase patient engagement in both pediatric and adult care [170-172].
Yet, the evaluation of patient portals among cancer inpatients is still limited, a knowledge
gap addressed by this study. We hypothesized that patient adoption of a portal and active
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use during a hospital stay may be associated with greater patient safety, postdischarge
care utilization and satisfaction, similar to outpatient settings. According to Karahanna et
al, adoption and continued use represent different behaviors [35]. Adoption is the initial
enrollment and signifies receptivity to the portal, while usage represents active
engagement, continued use after adoption. Therefore we distinguish between these 2
behaviors and evaluate them separately. Our specific aims were to 1) identify the key
patient factors predicting adoption and active inpatient use behaviors, and 2) examine the
association between portal use behaviors and adverse events, postdischarge utilization
(emergency visits and readmissions), and selected patient satisfaction measures (selfhealth management knowledge and satisfaction with the overall hospital experience).
MATERIALS AND METHODS
Study Setting and Description of the Portal
The site of the study was Mayo Clinic, Jacksonville, Florida (MCF), a large nonprofit,
specialized tertiary care practice and medical research center with more than 1.3 million
domestic and international patients seen each year. Physicians are salaried, not linked to
care volume, thus reducing monetary incentives in patient treatment. MCF contracted
with Cerner Solutions (Cerner Corp) to implement the patient portal and integrate it with
the system-wide electronic health record in 2010. When patients schedule an appointment
at MCF, they are invited to register for a portal account and are provided with
information on why and how to register. With each appointment reminder, patients
receive a reminder message to register for the portal. Portal invitations are also offered in
all outpatient waiting areas and displayed on electronic screens around the clinic.
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Once registered, patients’ are able to access informational functions, such as
viewing lab results, current medications, allergies, and diagnostic reports from clinic
visits and hospitalizations, and administrative functions, such as paying bills, processing
prescription refills, and coordinating appointments. A Continuity of Care Document, a
complete summary of patient current health status and history, is also available to view,
download, or forward to physicians at other hospitals. Additional information on MCF
patient portal is documented elsewhere [173]. Although the portal is designed for
outpatients, some functions are applicable to inpatient health information needs during
the hospital stay. Hospitalized patients potentially have time to access the portal when
they are not occupied with diagnostic testing or other activities [174]. For example, the
portal gives inpatients real-time access to laboratory results, admission notes,
consultation reports, and surgical notes, to view on their own time and between bedside
rounds. This functionality potentially facilitates patient communication and interaction
with the health care team during their stay, and empowers the patient to be more attentive
toward errors in documentation [158]. In addition, the medication function provides
patients with information on the type and purpose of their medications, including inhospital medication intake, which could enable patients to ask questions, review for
accuracy, or report medication discrepancies [32, 175]. Before home discharge, a
discharge summary and discharge instructions is uploaded to the portal, giving patients
time to review closely and ensure their understanding of home self-management
instructions. While the development of portal functionality for inpatients is in early
stages, the offered content may still help patients become more activated and improve
postdischarge care.
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Study Design and Participants
This was a retrospective review of patients satisfying the following criteria: 1)
adults 18 years of age or older, 2) cancer as a primary or secondary diagnosis at time of
hospitalization identified through the International Classification of Diseases, Ninth
Revision (ICD-9) codes, and 3) admitted to MCF between August 1, 2012, and July 31,
2014 (N=4,594). Per the unified theory of acceptance of use of technology, user
acceptance and intention to use a technology is followed by actual use [139]. Therefore,
we included the first hospitalization where a portal account had been established prior to
admission to examine consequent inpatient use. If the patient had not established a portal
account prior to any admission, then the first hospitalization in the study period was
selected. Patients who had a portal account prior to admission were defined as adopters,
and those without a portal account were nonadopters. Among adopters, inpatients who
logged in their portal during the hospital stay were active inpatient users and those who
never logged in were referred to as inactive inpatient users. The study was approved by
the Mayo Clinic Institutional Review Board.
Study Model
Our study was informed by Andersen’s Model of Healthcare Utilization [140].
The model was initially developed in 1968 to understand health services use and later
revised to include consumer satisfaction and dimensions of health status [142]. Shortly
after the model was developed, health services use was portrayed as a health behavior
influenced by multiple factors [141]. According to the World Health Organization, health
behavior is defined as “any activity undertaken by an individual, regardless of actual or
perceived health status, for the purpose of promoting, protecting or maintaining health,
whether or not such behavior is objectively effective towards that end” [143]. Because
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the portal is a tool to maintain and promote health, we considered portal adoption and use
as health behaviors that could be studied using Andersen’s model. As shown in Figure
4.1, we examined the influence of patients’ characteristics in three major components:
predisposing, enabling, and need factors, on portal adoption and use behaviors.

Environment

Patient Factors

Portal Behavior

Predisposing1

Adoption

Enabling2

Active
Inpatient Use

MCF

Outcomes

(1) Patient Safety:
Had an adverse event
(2) Post-discharge care
Utilization:
- Emergency visit within 14 days
- Unplanned readmission within 30
days
(3) Patient Satisfaction:
- Self-health management
knowledge
- Overall hospital experience

Need3

Figure 4.1 Study Theoretical Model Derived from Andersen’s Model of Healthcare
Utilization
1 Predisposing factors: age, sex, and race.
2 Enabling factors: marital status, employment status, health insurance type, and income.
3 Need factors: geographic area of residence, comorbidities, and frequency of
hospitalizations. Additional need factors related to the admission: MSDRG type and
APRDRG disease severity weight. APRDRG indicates All Patients Refined Diagnostic
Related Group; MSDRG, Medicare Severity-Diagnosis Related Group.
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Measures
Environment and Patient Characteristics
In this study, we assumed that all study participants had a common environmental
context, as all patients in MCF received their care in the same structure. Predisposing
determinants included age, sex, and race. Enabling determinants included marital status,
employment status, health insurance type, and median income in the residential ZIP code
less than Florida’s state median income, a surrogate for socioeconomic status. Need
factors included geographic area of residence, comorbidities, and frequency of
hospitalizations in the study period. Additional need determinants related to the hospital
admission included patient’s disease severity weight as measured by the 3M All Patients
Refined Diagnosis Related Groups (APDRG) classification system, and whether the
hospitalization was for medical or surgical treatment, based on the Medicare SeverityDiagnosis Related Group (MSDRG) codes [146].
Demographic data were extracted from the patient electronic health records. The
ZIP code median income was obtained from the 2006-2010 American Community
Survey and matched to the patient sample at the ZIP code level [144]. A count of
comorbidities included in Charlson Comorbidity Index during the 12 months prior to
hospitalization was documented [145].
Patient Safety, Utilization, and Satisfaction
We examined selected patients’ measures to investigate associations with portal
use. For patient safety, we studied the occurrence or otherwise of provider-reported, inhospital, adverse events, such as falls, accidental self-injuries, or other events related to
the surgery, vascular, equipment or devices, medication, or skin events, obtained from
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quality management services. For postdischarge utilization, we examined the occurrence
of emergency department visits within 14 days and unplanned readmissions within 30
days, both obtained from the hospital records. We measured patient satisfaction by
obtaining data from the Hospital Consumer Assessment of Healthcare Providers and
Systems (HCAHPS) survey. The survey is a validated instrument used since 2006 to
assess patients' perspectives of hospital care, and distributed to a random sample of
discharged patients between 2 days and 6 weeks after discharge [147]. While the survey
included many important questions, we selected the relevant items with highest response.
We measured patient self-health management knowledge with 2 questions: “When I left
the hospital, I had a good understanding of the things I was responsible for in managing
my health”, and “When I left the hospital, I clearly understood the purpose for taking
each of my medications”, and measured overall hospital satisfaction with 1 question:
“Using any number from 0 to 10, where 0 is the worst hospital possible and 10 is the best
hospital possible, what number would you use to rate this hospital during your stay”
[148]. Responses were transformed and averaged, resulting in a 0 to 100 linear-scaled
score.
Data Analysis
We described the characteristics of cancer patients according to their portal
adoption and inpatient activity behaviors and examined differences between groups using
Pearson χ2 and Wilcoxon nonparametric tests. Multivariate regression models were
conducted to predict factors associated with portal adoption and active inpatient use, as
well as to examine the association between selected outcomes and portal behaviors. All
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analyses were conducted in SAS Version 9.4 (SAS Institute Inc, Cary, North Carolina,
USA), and significance was defined as P<.05.
RESULTS
Participants, Adopters, and Active Inpatient Users
Of the 4,594 study-eligible hospitalized patients with cancer, 2,352 (51.2%) had a
portal account prior to admission (ie, adopters), of whom 632 (26.8%) used the portal
account during their hospital stay (ie, active inpatient users). Patient characteristics at
admission were reported in Table 4.1. Significant differences in patient characteristics
were present among portal adoption and inpatient use behaviors (Table 4.2). Adoption
was influenced by a majority of predisposing and enabling factors, such as age, sex, race,
marital status, employment status, income, and type of health insurance. While active
inpatient use was similarly influenced by predisposing and enabling factors, such as age,
race, and marital status, we found greater influence associated with need, such as having
greater disease severity, being nonlocal, and admitted for medical rather than surgical
treatment.
Bivariate Associations of Portal Behaviors With Adverse Events, Care Utilization, and
Patient Satisfaction
Bivariate associations of portal adoption with our selected measures (Table 4.3)
showed that adopters had more emergency visits and readmissions than nonadopters,
while reporting higher self-health management knowledge. Similarly, active inpatient
users had more readmissions than inactive inpatient users, and marginally higher selfmanagement scores. Logistic and linear regression analyses showed that after adjusting
for age and disease severity, the association between portal behaviors and majority of our
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assessed measures were not significant (Table 4.4). Adverse events and overall hospital
experience did not differ among groups in either univariate or multivariate regression
analyses (P>.05).
DISCUSSION
To date there remains a gap in the literature evaluating the use of inpatient portals
among cancer patients. This study provides important information to clinicians,
administrators, and researchers, on the key patient determinants associated with portal
adoption and use. Prior studies reported significant interest in patient portals among
oncology populations [64, 74, 176]. Yet, to our knowledge, this is the first study to
examine portal use in a large inpatient oncology cohort. In this sample, we found that
portal adoption and use during hospitalization has reached modest levels and somewhat
higher usage than published reports on inpatient portal use. Over half of our inpatient
oncology population voluntarily adopted the portal before hospital admission and 27%
actively used the portal during the stay. Dumitrascu et al found that of 44.2% patients
who had a portal account at the time of admission, only 20.8% accessed the portal during
their stay [173]. Davis et al found that of 34.4% registered portal patients, 23.4% used it
while hospitalized [26]. Robinson et al reported that 16% of surgical inpatients with a
portal account used it while being in the hospital [177].
There were noteworthy differences in patient characteristics between adopters and
nonadopters in a majority of predisposing and enabling factors. Portal adoption increased
among patients who were female, married, and with higher income, and decreased among
patients who were African American, unemployed, and had governmental health
insurance. Interestingly, the likelihood of portal adoption was similar for patients aged 65
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to 75 years as the middle-aged adults 45 to 55 years, contradicting popular beliefs that
older patients were less likely to engage in health technologies [178]. Portal adoption,
however, considerably decreased among patients aged over 75 years. Similar to our
findings, portal use among outpatient oncology patients was reported to be greater among
younger, white patients, and those with upper aerodigestive malignancy diagnosis,
greater disease severity, and case complexity [24]. Among nononcology populations, a
similar digital divide was reported by age groups, race/ethnicity, income, and education
[20, 83, 86, 88, 179, 180]. Our findings showed higher portal adoption among those with
more frequent hospitalizations, which was the only notable need determinant. Other
studies have reported higher interest in the portal among those with more medical
problems, greater severity of illness, or higher than average clinical need [14, 55, 85, 87].
Similarly, inpatient portal use increased with younger age and being married, but
more influenced with need determinants. Active access was associated with residing
outside the city of Jacksonville (nonlocals); suggesting that commuting patients found
health information important to view during the stay. Additionally, access was greater
among those with higher disease severity and those admitted for medical rather than
surgical treatment. Medical admissions for cancer patients are usually associated with
investigating the origin and cause of disease, or evaluating chemo or radiation treatments,
compared to surgical admissions that involve typical procedural routines and surgical
recovery that may fully occupy the patient’s time in the hospital [181]. Because a cancer
diagnosis is a stressful life event, patients’ information-seeking behavior was thought to
become more active, possibly as a coping strategy to overcome uncertainties [23, 74,
182].
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Patient Safety
Several studies have assumed that information technology systems have the
potential to improve patient safety by identifying errors in medications and preventing
adverse drug reactions. Yet, limited evidence exists regarding the effectiveness of a portal
as a tool in reducing adverse events. One recent study by Kelly et al found that 8% of
parents with hospitalized children recognized errors in their child's medication list after
using an inpatient portal application [172]. Further optimistic views about the ability of
portals to reduce errors were derived from patient participation in care, where patients
could notify clinicians of their medication allergies, unexpected toxicity symptoms, and
lapses in care to prevent adverse events [31, 175, 183, 184]. Among surgical inpatients
who were portal users, postoperative infection was their most frequent ICD-9 code,
suggesting that experiencing a safety-event may activate patients to follow up their
personal health information to avoid further complications [177]. In contrast to this
evidence, our study did not find an association between portal adoption or use and
adverse events. Likewise, a randomized controlled trial by Weingart et al did not find
sufficient evidence to support an association between adverse drug events and portal use
[32]. Earlier research reported that patient history evaluation in cancer care is more
focused, providing the patient an opportunity to recall medical and medication
information to prevent errors. [185, 186] In addition, most adverse events at hospitals are
underreported and the events in our data were limited to those reported by providers. A
new initiative within the portal that is gaining popularity and has the potential to prevent
errors is the OpenNotes national movement, which invites patients to read their clinicians'
notes online and report back errors or safety concerns that, in turn, may avert mistakes
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from happening [187, 188]. Hence, it opens up a new possibility to engage patients as
safety partners through their reported documentation errors.
Utilization
Studies that examined the effect of portal use on subsequent utilization of health
services showed mixed results [14, 20, 189]. A study using propensity score matching
found no difference between portal users and nonusers on clinical service utilization
[190]. Among members of Kaiser Permanente, a retrospective study in the Northwest
found that patient access to an online portal was associated with decreased rates of
primary care office visits and phone calls [191], whereas the opposite was found by Palen
et al where portal users had higher rates of office visits, phone encounters, after-hour
clinic visits, emergency department visits, and hospitalizations [192]. The assumption
was that if patients could view personal health information, they will be more aware, able
to manage their health, and need less emergency service or hospitalizations. This
expectation was not validated in our study, suggesting that a portal technology may be a
complementary technology and does not substitute for health services needs of oncology
patients. Mayer et al reported 77.2% of cancer patients’ visits to the emergency
department were due to pain, respiratory problems, and gastrointestinal issues, with
63.2% of those visits resulting in hospital admission [193]. Barbera et al reported that
83.8% of cancer patients who died had visited the emergency department during their
final 6 months of life with issues related to abdominal pain, dyspnea, pneumonia, fatigue,
and pleural effusion [194]. Shapiro et al found that those who had surgery during their
index admission were 3 times more likely to be readmitted [195]. Weaver et al examined
cancer inpatients and found 48% of readmissions were within 1 to 2 days of discharge
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[196]. Donze et al developed a predictive model and found that discharge from an
oncology service was a significant predictor of unplanned readmission [197]. Similarly, a
recent systematic review reported that comorbidities, older age, advanced disease, and
index hospitalization length of hospital stay were significant predictors for readmission in
oncology [198]. Thus, emergency department visits and readmissions may be influenced
more by the nature of illness, treatment-related complications, and other such factors than
avoidable reasons by portal use.
Patient Satisfaction
Our findings suggest limited evidence of the relationship between patient
satisfaction and portal use. Self-management knowledge scores appear to be considerably
higher among both adopters and inpatient users in bivariate associations; however, in
regression analyses, associations with satisfaction were somewhat attenuated and no
longer statistically significant. Our interpretation of results needs to be cautiously taken
as they were limited by the random selection of sample surveyed and the selection of
self-management questions. In addition, we have no assessment of self-health
management knowledge at baseline. Therefore, the association between portal use and
self-health management knowledge may have already been existed.
Prior research has shown inconsistent conclusions regarding associations between
portal use and patient satisfaction; with wide variability in the offered portal features, the
outcomes evaluated, and the populations studied [14, 18, 19, 163]. In addition, the
potential of patient portals for patients with chronic conditions was available, but
relatively nascent for cancer [199]. Among chronically ill patients, the portal showed
promise for improving diabetic patients’ satisfaction with care, ability to self-manage,
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and adhering to treatments [200]. This has been accompanied by evidence of improved
blood pressure control among people with newly diagnosed hypertension [201]. Patient
portal access was also superior in general adherence and satisfaction with doctor-patient
communication among patients with congestive heart failure [80, 202]. Yet, not all
findings in the literature showed that patients with chronic conditions were amenable to
improved outcomes with portal use [74, 203-205].
There are many potential recommendations to improve portal functions for
inpatients. Hospitals often provide patients and families with standard information on
disease and treatment options while being hospitalized, but that is not always enough
[206]. An effective tool for awareness and self-management may include problemsolving support, regular education provision, treatment options with cost estimations that
aid patient decision making, and consistent patients training on how to take responsibility
for their own health [207].
It should be noted that emotional factors, such as anxiety or low self-efficacy,
may dramatically influence self-management or symptom-coping behaviors [208, 209].
Of interest, some researchers suggest technology-based applications to provide
recreational social supports to help patients cope with their illness. O’Leary et al reported
favorable patient perceptions toward games offered in the hospital-based portal [94]. The
same was reported by Jameson et al, who indicated that electronic gaming can be a
positive distraction away from pain [210]. Innovative social support approaches offering
recreational avenues via the portal may attract more users, which in turn, may improve
self-management, symptom-coping, and quality of life [211]. Thus, greater attention is

63

needed to improve the portal content and functionality for inpatients to improve patient
outcomes.
This study has a number of limitations. There is limited generalizability given that
our oncology cohort was from a single center. Technology limitations restricted our
analysis; we could not examine frequency of inpatient log-ins, or distinguish if a portal
activity was carried out by the patient or a delegated family member. Further, it would be
interesting to understand if there was a dose-response type curve associated with portal
use but information on the extent of use was not available. Post-discharge utilization
measures were limited to care utilization at MCF, with no data on utilization elsewhere.
Conclusions regarding patient safety and satisfaction measures were limited by the range
of variable values; adverse events were uncommon, and patient satisfaction was almost
uniformly high among all patients. Finally, low response to the HCAHPS resulted in a
small sub-sample size to analyze satisfaction, a major limitation, but no other measures
were readily available. Despite these limitations, the study uncovered determinants of
adoption and use behaviors among a large sample of hospitalized cancer patients.
Additionally, it adds new information to the growing body of literature on inpatient
engagement using acute care portals. Future research directions should investigate the
extent of inpatient portal use, incorporate inpatient-centered education materials, and
improve the portal with functions that add the most value for cancer inpatients.
CONCLUSIONS
We found that cancer patients had reached modest levels of portal adoption.
While portal adoption increased with predisposing and enabling determinants (eg: age,
sex, marital status, income), active inpatient use increased with need (eg: commute
residence and high disease severity). While these findings should be cautiously
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interpreted, the study adds to the growing evidence that patient portals should be further
addressed for inpatient care. Particularly, the study provides insights for the informatics
research community and those interested in improving inpatient care and selfmanagement support through technology.
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Table 4.1 Sample Baseline Characteristics by Portal Behaviora
Characteristics

Adopters
(n=2,352)

Nonadopters
(n=2,242)

P
value

Active
Inpatient
Users
(n=632)

Inactive
Inpatient
Users
(n=1,720)

P
value

62.3 (14.0)

65.4 (14.8)

<.01b

60.2 (14.3)

63.0 (13.8)

<.01b

259 (11.0)

191 (8.5)

<.01c

82 (13.0)

177 (10.3)

<.01c

339 (14.4)

281 (12.5)

106 (16.8)

233 (13.5)

632 (26.9)

480 (21.4)

185 (29.3)

447 (26.0)

702 (29.8)

652 (29.1)

166 (26.3)

536 (31.2)

339 (14.4)

454 (20.2)

80 (12.7)

259 (15.1)

81 (3.4)

184 (8.2)

13 (2.1)

68 (4.0)

Age group (years)
Mean (SD)
≤44
45-54
55-64
65-74
75-84
≥85

.22c

Sex
Female

1,148 (48.8)

1,055 (47.0)

Male

1,204 (51.2)

1,188 (53.0)

295 (46.7)

852 (49.5)

337 (53.3)

869 (50.5)

<.01c

Race/ethnicity
African American

.25c

<.01c

121 (5.2)

273 (12.4)

18 (2.9)

103 (6.1)

White

2,120 (91.3)

1847 (84.0)

575 (91.9)

1,545 (91.2)

Other

80 (3.4)

78 (3.5)

33 (5.3)

47 (2.8)

<.01c

Marital status
Married
Single/divorced/wi

<.01c

1,786 (75.9)

1,454 (64.9)

506 (80.1)

1,280 (74.4)

566 (24.1)

788 (35.1)

126 (19.9)

440 (25.6)

dowed
<.01c

Employment status

.79c

Employed

739 (37.7)

547 (28.9)

206 (38.1)

533 (37.5)

Retired

836 (42.6)

935 (49.4)

208 (38.5)

628 (44.2)

Not employed/

386 (19.7)

411 (21.7)

126 (23.3)

260 (18.3)

disabled
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<.01c

Income

.54c

< FL median

645 (28.3)

803 (37.2)

167 (26.5)

478 (27.8)

=> FL median

1,707 (71.7)

1,439 (64.1)

465 (73.5)

1,242 (72.2)

<.01c

Health insurance type

<.01c

Commercial/self

1,145 (48.7)

815 (36.4)

339 (53.6)

806 (46.9)

Medicare/Medicaid

1,207 (51.3)

1,427 (63.6)

293 (46.4)

914 (53.1)

/other government
.89c

Area of residence
Nonlocal
Local

<.01c

521 (22.2)

493 (22.0)

166 (26.3)

335 (20.6)

1,831 (77.8)

1,749 (78.0)

466 (73.7)

1,365 (79.4)

Comorbidity d

.58c

.32c

None

1,115 (47.4)

1,052 (46.9)

289 (45.7)

826 (48.0)

One or more

1,237 (52.6)

1,190 (53.1)

343 (54.3)

894 (52.0)

CHF

145 (6.2)

171 (7.6)

.05c

51 (8.1)

94 (5.5)

.02c

Peripheral vasc.

322 (13.7)

338 (15.1)

.18c

83 (13.1)

239 (13.9)

.63c

Cerebrovascular

165 (7.0)

224 (10.0)

<.01c

42 (6.6)

123 (7.2)

.67c

Chronic pulmonary

262 (11.1)

256 (11.4)

.77c

61 (9.7)

201 (11.7)

.16c

Mild liver disease

432 (18.4)

291 (13.0)

<.01c

129 (20.4)

303 (17.6)

.12c

Diabetes mellitus

392 (16.7)

351 (15.7)

.35c

115 (18.2)

277 (16.1)

.23c

Mod./sev. renal

196 (8.3)

179 (8.0)

.66c

53 (8.4)

143 (8.3)

.96c

Mod./sev. liver

121 (5.1)

86 (3.8)

.03c

49 (7.8)

72 (4.2)

<.01c

Comorbidity typee

<.01b

Frequency of
hospitalizations

1.8 (1.5)

1.4 (1.1)

mean (SD)
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<.01b
2.0 (1.7)

1.7 (1.4)

<.01b

Admission type based
on MSDRG
Surgical

<.01b

1,504 (63.9)

1,315 (58.7)

348 (55.1)

1,156 (67.2)

848 (36.1)

927 (41.3)

284 (44.9)

564 (32.8)

Medical
.24b

APRDRG weight
Mean, (median,

2.5 (1.5, 2.9)

2.3 (1.5, 2.3)

SD)

<.01b
3.1 (1.9,

2.3 (1.4, 2.6)

3.6)

Abbreviations: APRDRG, All Patients Refined Diagnosis Related Group; MSDRG,
Medicare Severity-Diagnosis Related Group.
a
Data are reported as No. (%) for count variables and mean (SD) for continuous
variables.
b
Wilcoxon nonparmetric.
c
Pearson χ2 test.
d
Comorbidity groups are not mutually exclusive as a patient may have more than 1
comorbidity diagnosis.
e
Comorbidity type was reported for diseases with > 5% of patients.
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Table 4.2 Logistic Regression Analysis Showing the Predictors of Portal Behaviors
Odds Ratio (95% CI)a
Factors

Predisposing

Characteristics
Adoptionb

Active Inpatient Usec

44-

1.42 (1.03, 1.95)

1.89 (1.16, 3.06)

45-54

1.10 (0.82, 1.47)

1.73 (1.10, 2.72)

55-64

1.22 (0.95, 1.57)

1.48 (1.00, 2.19)

1.00

1.00

75-84

0.71 (0.57, 0.87)

1.08 (0.75, 1.56)

85+

0.36 (0.24, 0.54)

0.77 (0.34, 1.75)

1.00

1.00

1.26 (1.10, 1.45)

0.97 (0.78, 1.21)

White (reference)

1.00

1.00

African American

0.34 (0.27, 0.45)

0.51 (0.29, 0.89)

Others

0.84 (0.58, 1.23)

1.39 (0.82, 2.37)

1.00

1.00

1.60 (1.37, 1.87)

1.49 (1.14, 1.94)

1.00

1.00

Retired

1.04 (0.83, 1.30)

1.04 (0.75, 1.46)

Not employed/disabled

0.70 (0.57, 0.86)

1.04 (0.77, 1.40)

Age

65-74 (reference)

Sex
Male (reference)
Female
Race

Enabling

Marital status
Divorced/single/widowed
(reference)
Married
Employment
Employed (reference)
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Health insurance type
Commercial (reference)
Medicaid/Medicare

1.00

1.00

0.76 (0.61, 0.95)

1.07 (0.77, 1.50)

1.00

1.00

1.39 (1.20, 1.60)

1.10 (0.87, 1.39)

1.00

1.00

1.13 (0.96, 1.33)

1.34 (1.04, 1.71)

1.00

1.00

1.05 (0.91, 1.21)

0.97 (0.77, 1.22)

1.43 (1.33, 1.55)

1.08 (0.99, 1.19)

-

1.00

Income
< FL median (reference)
=> FL median
Need

Area of residence
Local (reference)
Nonlocal
Comorbidities
None (reference)
1+
Frequency of
hospitalizations
MSDRG type d
Surgical (reference)
Medical

2.17 (1.68, 2.78)

APRDRG weight d

-

a

1.13 (1.09, 1.17)

Bold values are statistically significant at P<.05. Odds ratios greater than 1 imply
increased chance for behavior; less than 1 imply decreased chance for behavior.
b
Predictors for adoption: age, sex, race, marital status, employment status, income, health
insurance type, and frequency of hospitalizations.
c
Predictors for active inpatient use: age, race, marital status, geographic area of residence,
APRDRG weight, and MSDRG type.
d
Variables related to the hospital admission were not examined among adopters as the
adoption behavior was established prior to admission.
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Table 4.3 Adverse Events, Postdischarge Care Utilization and Patient Satisfaction Among the portal Behavior Groups
Measures

Outcomes

Adopters

Nonadopters

(n=2,352)

(n=2,242)

P value

Active Inpatient

Inactive

P

Users (n=632)

Inpatient Users

value

(n=1,720)
40 (1.7)

47 (2.1)

.36a

13 (2.1)

27 (1.6)

.42a

272 (11.6)

214 (9.5)

.03a

75 (11.9)

197 (11.5)

.78a

299 (12.7)

222 (9.9)

<.01a

96 (15.2)

203 (11.8)

.03a

87.6 (19.6)

85.5 (20.1)

.02b

89.1 (18.4)

87.1 (20.0)

.22b

medication, mean score (SD)

90.0 (18.8)

87.8 (20.9)

.05b

91.8 (16.0)

89.4 (19.7)

.21b

Aggregate self-health management

84.3 (21.3)

80.0 (23.1)

<.01b

87.0 (19.2)

83.3 (21.9)

.05b

95.6 (9.1)

95.3 (10.3)

.75b

95.6 (10.5)

95.7 (8.6)

.56b

Patient safety

Had an adverse event, No. (%)

Postdischarge

Emergency visit within 14-days of

care utilization

discharge, No. (%)
30-day unplanned readmission, No. (%)

71

Patient

Understand responsibilities for self-health

satisfactionc

management, mean score (SD)
Understand the purpose for taking each

knowledge score
Overall rating of the hospital stay, mean
score (SD)

a

Pearson χ2 test. bWilcoxon nonparametric. cSatisfaction survey was distributed to a random sample of discharges; thus, the sample
size was as follows: adopters; n=788, nonadopters; n=646, active inpatient users; n=205, and inactive inpatient users; n=577.

Table 4.4 Association Between Patient Outcomes and Portal Behaviors: Results From Regression Models
Independent Variables
Active Inpatient Users vs Nonadopters
Dependent Variablesa
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a

Inactive inpatient Users vs Nonadopters

OR (95% CI)

P value

OR (95% CI)

P value

[adverse events=yes]

0.76 (0.40, 1.45)

.41

0.71 (0.44-1.16)

.17

[emergency visits=yes]

1.28 (0.97, 1.70)

.08

1.23 (1.00-1.51)

.08

[readmissions=yes]

1.60 (1.23, 2.08)

<.01

1.21 (0.99-1.48)

.06

Dependent Variablesa

Beta Coefficient

P value

Beta Coefficient

P value

Self-health management knowledge

2.18

.07

1.15

.17

Overall hospital experience

0.16

.83

0.28

.60

Five regression models were conducted adjusting for age and disease severity. A logistic regression was used for adverse events,
emergency visits, and readmissions. A linear regression was used for self-health management knowledge and overall hospital
experience scores.

CHAPTER 5
Manuscript II Femoral and Sciatic Nerve Block Versus Periarticular
Anesthetic Injection After Total Knee Arthroplasty

ABSTRACT
Background: Pain is a main concern of patients undergoing total knee arthroplasty
(TKA). Questions/Purposes: This study compares whether receiving a periarticular
anesthetic injection (PAI) of ropivacaine, epinephrine, ketorolac, and morphine versus
femoral nerve block (FNB) combined with single-shot sciatic nerve block (SNB) offers
better patient outcomes. Patients and Methods: We retrospectively reviewed
consecutive patients who underwent primary unilateral TKA between March 1, 2013, and
August 31, 2014 (N=511) and received FNB with SNB versus those who underwent
TKA between October 1, 2014 and March 31, 2016 (N=479) and received PAI.
Postoperative outcomes, including pain scores, time to first ambulation, cumulative
distance walked, in-hospital falls, length of stay, discharge disposition, satisfaction with
pain control, emergency visits within 14 days, readmissions within 30 days, revisions
within 90 days, and total cost of hospitalization and 90-day follow-up period, were
compared. Results: The PAI group had lower pain scores during the first 24 hours after
TKA, but there was no difference at 48 hours. Patients who received PAI had earlier
ambulation, longer walking distance, shorter hospital stay, increased discharges home,
and better satisfaction with pain control.
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Total cost of hospitalization was less expensive for PAI; on average, each patient who
had their pain managed using PAI saved $3,539. Insignificant differences were found in
other variables. Conclusions: PAI is superior in providing early postoperative pain relief,
improved functional recovery, better patient satisfaction with pain, and lower
hospitalization cost compared to FNB with single-shot SNB following TKA.
Level of Evidence: III
Keywords: Femoral nerve block, Periarticular injections, Pain control, Cost, Total knee
arthroplasty

INTRODUCTION
Total knee arthroplasty (TKA), also known as total knee replacement, was the
third most common operating room procedure (718,000 procedures) in the United States
in 2011, with an aggregate hospitalization cost of $11.3 billion per year [131]. TKA is
projected to increase to 3.48 million procedures per year by 2030 due to population aging
and obesity, contributing to further growth in health care spending [52, 53]. The wide
diffusion and high cost of this procedure has led clinicians to focus on pain management,
since severe pain has profound implications on patients’ recovery [107, 108].
Accordingly,

medical

and

economic

consequences

are

expected,

including

dissatisfaction, prolonged length of stay (LOS), and increased cost [212]. Thus, effective
pain control is crucial to improve clinical care and avert unfavorable outcomes. Given the
importance of pain management, the Joint Commission and the Agency for Healthcare
Quality and Research introduced standards for organizations to improve their care for
patients with pain [213, 214].
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In the last few years, advancements in postoperative pain control moved toward
multimodal pain management methods, instead of using opioids alone [109]. Of these
approaches, femoral nerve block (FNB), which is a well-established analgesic to reduce
pain post-TKA, has been the gold standard [110, 111]. However, many authors reported a
number of disadvantages, including quadriceps weakness that delays recovery, increased
risk of neurologic symptoms, falls, opioid abuse, and adverse events [43, 112, 113]. For
this reason, some clinicians combine sciatic nerve block (SNB) with FNB, instead of
using FNB alone, in order to improve outcomes early after surgery [114-118]. Yet, the
advantages of SNB when combined with FNB continue to be debated in the literature
[119, 120].
Compared with peripheral nerve block, periarticular anesthetic injection (PAI), a
concentrated multidrug combination, has been identified as a preferred alternative
approach for pain management after TKA [121]. Earlier clinical studies were conducted
to validate the efficacy and safety of different combinations of PAI medication mixture,
and have reported it to be easier to administer with fewer adverse events [122-124].
However, evidence on PAI as a better alternative to other pain management approaches is
limited, and research is needed to support its efficacy [132-136].
For several years, our institution had used continuous FNB combined with a
single-shot SNB and 0.5% ropivacaine for postoperative pain control after TKA. In
September 2014, the orthopedic practice showed interest in pursuing a change in the pain
management approach after TKA, and transitioned to use of PAIs. Thus, comparing the
analgesic effect and other related patient outcomes among patients who used FNB with
SNB versus PAI was a topic of interest. Outcomes were evaluated postoperatively,
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including pain scores at 24 and 48 hours after surgery, time to first ambulation,
cumulative distance walked, patient falls, LOS, discharge disposition, patient satisfaction
with pain control, and postdischarge measures, including emergency visits within 14
days, readmissions within 30 days, and revisions within 90 days. We also compared
detailed cost per type of service and total cost for both the hospitalization episode and the
90-day follow-up period, separately, for these 2 pain management approaches.
To our knowledge, there are few reports comparing efficacy, safety, and cost of
FNB combined with SNB versus PAI in TKA. Our motivation was to examine if the
latter approach was cost-effective. We found limited research available to inform policy
on drivers of health care costs in TKA; therefore, results of this study may add value to
policy-makers and clinicians who are interested in pain management in orthopedic care.
Because many surgical procedures have migrated to the outpatient setting, many
orthopedic surgeons are interested in pain control approaches that enable easier and safer
outpatient TKA that can be provided at lower cost. It is equally important to disseminate
results of this comparison to patients, which may empower them to take an active role in
their care and make more informed decisions.
MATERIALS AND METHODS
We conducted a retrospective review of patients at least 18 years of age who
received a primary unilateral TKA. A total of 1,158 TKA patients were screened to
obtain 990 eligible patients for the study (Figure 5.1). Study outcomes were compared
between patients who received FNB combined with single-shot SNB between March 1,
2013, and August 31, 2014, versus patients who received PAI between October 1, 2014,
and March 31, 2016). Surgeries in September 2014 were excluded to allow the new
practice to stabilize.
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The surgical procedure, implants used, and surgery team were consistent in the 2
periods, minimizing differences in patient and provider factors. Table 1 shows most
patient characteristics are similar. All patients received a primary general or spinal
anesthesia by an anesthesiologist using the same preprocedure sedation protocol.
Combined FNB with SNB or PAI were additional anesthesia given for postoperative pain
control. For all patients in the FNB group with no notable valgus deformity or
radiculopathy, the same anesthesiologist administered an indwelling continuous femoral
catheter supplemented with a single-shot SNB. For patients in the PAI group, the
anesthetic mixture was administered based on weight, as previously used by Spangehl
and colleagues [50]. PAI was administered by the performing surgeon, minimizing the
potential for confounding effects on injection technique. The injection was administered
by 18-gauge needle as multiple boluses into the periarticular tissue surrounding the knee
joint prior to site closure, with no additional infusion or injections after site closure. A 30
cc bolus was injected into the posterior capsule and the remaining boluses were injected
throughout the anterior knee periarticular and subcutaneous tissues. Postoperative pain
control was the same for both groups and included use of analgesia, such as morphine,
acetaminophen, celecoxib, tramadol, and narcotics, administered via oral or intravenous
means as necessary.
Patient Characteristics
Patient demographic and clinical data were obtained from the electronic health
record (EHR). Comorbidities were counted by the presence of any of the 19 common
chronic medical conditions included in the Charlson Comorbidity Index, in addition to
hypertension, stroke, anxiety, and depression in the 12 months prior to hospitalization.
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Obesity was determined by the body mass index (BMI) documented at time of admission,
rather than on the International Classification of Diseases code for obesity, which is
rarely coded. We then classified BMI using weight categories defined by the Centers for
Disease Control and Prevention. American Society of Anesthesiologists physical status
classification was used to classify patient disease severity on admission.
Study Measures
Pain was assessed postoperatively using a numeric rating scale ranging from 0 (no
pain) to 10 (worst possible pain) and reported at 24 and 48 hours after surgery. Patient
functional recovery was measured by time from end of surgery to first walk, and by
distance walked each day as documented in physical therapy (PT) notes. An attempt was
made for each patient to receive a PT session on the same day of surgery, with a
standardized protocol to assist in knee ambulation, standing, and walking. Because some
patients rejected PT after surgery due to pain or other reasons, the frequency of received
PT sessions varied between cohorts. Thus, our calculation of distance walked was
exclusive to the first 3 PT sessions, which was the minimum number of sessions received
by all patients.
All patients had TKA on the day of admission, thus, we documented hospital
LOS, in hours, throughout the hospitalization and from the end of surgery to discharge.
Patient falls and surgical site infections were obtained from the Quality Management
Services database for adverse events. Additionally, discharge disposition, emergency
visits within 14 days after discharge, readmissions within 30 days, and revisions within
90 days were extracted from the EHR.
Patient satisfaction was measured by the normal hospital procedure, using the
validated Hospital Consumer Assessment of Healthcare Providers and Systems
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(HCAHPS) survey; distributed to a random sample of discharged patients ranging
between 2 days and 6 weeks after discharge [148]. Thus, only a subset of our patients
were assessed; 185 (36.2%) from the FNB group and 199 (41.5%) from the PAI group.
We selected 2 questions to assess satisfaction with pain: “How often was your pain well
controlled?” and “How often did the hospital staff do everything they could to help you
with your pain?” Responses were transformed and averaged (never=0, sometimes= 33.3,
usually=66.6, and always=100), resulting in a 0 to 100 linear-scaled score. One question
assessed the overall satisfaction with hospital experience: “Using any number from 0 to
10, where 0 is the worst hospital possible and 10 is the best hospital possible, what
number would you use to rate this hospital during your stay?” Scores were multiplied by
10 to create a consistent linear scale.
Cost data were obtained from our institution’s cost data warehouse [151], which
applied Medicare reimbursement to professional services, multiplied service line hospital
charges by Medicare cost report cost-to-charge ratios, and adjusted for inflation with the
gross domestic product implicit price deflator to create 2016 standardized costs. We
reported costs separately for the index hospitalization and 90-day follow-up period
excluding hospitalization, using Berenson-Eggers Type of Service and Uniform Billing04 codes to classify the line item data. We further summed cost by type of service,
grouped in different categories: analgesic approach (i.e., nerve block and the periarticular
supplies and medications); room and board (i.e., observation and intensive care unit stay);
operating and recovery room occupation; orthopedic procedure; physical therapy; pain
medications; laboratory and pathology; supplies; and other costs including blood
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transfusion, other medications/intravenous fluids, and miscellaneous. Follow-up cost data
did not include medications obtained from outpatient pharmacies.
Data Analysis
Statistical analyses were performed using SAS Version 9.4 (SAS Institute Inc.);
significance was defined as P<.05 in a 2-tailed test. We performed univariate χ2 tests for
categorical variables with Fisher's exact test for cell counts <40, and Wilcoxon signed
rank tests for mean comparisons among continuous variables to account for skewed
distributions. Cost variables were presented as mean and median cost per patient,
including SDs and interquartile ranges. We used repeated generalized linear regression
models to determine if receiving PAI was a predictor for (1) pain scores at 24 hours, (2)
pain scores at 48 hours, (3) distance walked, (4) postoperative LOS, and (5) total cost of
index hospitalization. Independent variables in the regression analysis included age, sex,
race, marital status, BMI, ASA class, and comorbidities.
In modelling the index hospitalization total cost, we used log-transformed costs.
For the 90-day follow-up period, we excluded patients with costs exceeding $20,000 not
related to TKA and patients who were electively readmitted for major surgeries, and
focused on local patients (n=263 and n=278 for FNB and PAI patients, respectively), who
were more likely to have follow-up services performed at our institution. This study was
approved by the institutional review board, and no external source of funding was
obtained.
RESULTS
Of the total population, more than 99% of patients had their TKA as an elective
procedure. The majority were white (91.3%), married (74.0%), women (61.5%), living
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locally in Jacksonville, Florida (57.1%), with a mean age of 68.0 years (SD 9.4 years).
With regards to comorbidities, 55.3% did not have any comorbid conditions reported in
the last 12 months, and among those who did have comorbidity, 25.7% were
hypertensive, 10.2% were diabetic, and 6.5% suffered from cancer. Patient demographic
and clinical characteristics were similar in both FNB and PAI groups, except for ASA
class that was included as a covariate in regression analyses. Baseline characteristics are
reported in Table 5.1.
Postoperative Outcomes
Analgesic Efficacy: Patient pain scores at 24 hours after surgery were significantly lower
in the PAI group (2.2 [1.5]) versus the FNB group (2.8 [1.7]; P< .01). No significant
differences were reported between the groups in the next postoperative day (24-48
hours). Statistical tests were not performed for 48 and thereafter, due to the limited
number of patients remaining to be hospitalized (Table 5.2).
Functional Recovery: Patients in the PAI group experienced earlier ambulation, where
33 (6.8%) walked on the day of surgery compared to 4 (0.8%) in the FNB group (P<.01).
Distance walked was also higher among the PAI group (86.5 meters [82.2]) than the FNB
group (48.0 meters [67.0]; P<.01) in the first 3 PT sessions. We also noted fewer patient
falls among the PAI group, but differences were not statistically significant (P>.05)
(Table 5.2).
Other Outcomes: We found patients in the PAI group had a significant decrease in
postoperative LOS by about 14.4 hours, from 71.2 hours with FNB to 56.8 hours with
PAI (P<.01). In addition, 382 (79.3%) patients who received PAI were able to be
discharged home rather than to other care or rehabilitation facilities, compared with 248

81

(48.2%) who received FNB. We found 4 PAI cases with surgical site infections, while
none were seen among the FNB patients (P=.05), but no significant differences were
detected in emergency visits, readmissions, and revisions (Table 5.2).
Patient Satisfaction
Patient satisfaction with pain control was significantly higher among patients in
the PAI group compared to FNB (P<.01), but no differences were observed in the overall
hospital experience (Table 5.3).
Cost
The total standardized cost of hospitalization was 22.8% more expensive for pain
management using FNB combined with single-shot SNB compared to PAI ($15,542
[$2,464] vs $12,002 [$3,079]; P<.01). Differences in cost per type of service between the
2 pain management approaches were significant in almost all categories (Table 5.4 and
Figure 5.2). However, the total cost throughout the 90-day period after discharge was
similar for the 2 pain management approaches (Table 5.5).
PAI as a Predictor for Study Outcomes
As a secondary analysis, we applied several linear regression models to test if PAI
(independent variable) was a predictor for selected study outcomes, including pain scores
at 24 and 48 hours, time to first ambulation, distance walked, postoperative LOS, and
total cost of hospitalization after adjusting for patient demographic and clinical factors.
Our results indicated that receiving PAI was a significant predictor for lower pain at the
first 24 hours postoperatively (β=-0.55, P<.01), earlier ambulation (β=-8.88, P<.01),
further distance walked (β=27.42, P<.01), shorter postoperative LOS (β=-13.72, P<.01),
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and lower hospitalization cost (β=-0.26, P<.01; $4,040 savings). Regression model
results are presented in Table 5.6.
DISCUSSION
Both FNBs with single-shot SNB and PAIs have been widely used to alleviate
postoperative pain after TKA. Our retrospective study was conducted to determine
whether using PAI had advantages on patient outcomes compared to FNB with SNB in
the immediate postoperative time period. Based on study results, patients who received
PAI reported lower pain scores at 24 hours after TKA and were more satisfied with pain
control. PAI patients were able to ambulate earlier, walk further, and be discharged
sooner, and to home rather than a rehabilitation center. In addition, findings from
adjusted regression models provided further evidence of the positive association between
using PAI and these patient outcomes.
A likely key to patient recovery is controlling postoperative pain [215]. The
psychological factor of feeling better after a major surgery like TKA, known to be a
painful procedure, could increase patient motivation to engage in rehabilitation and
recovery efforts [216, 217]. As the PT protocol in our institution began on the day of
surgery, patients in the PAI group who experienced less pain were more able to initiate
therapy immediately after TKA. In return, earlier mobility and improved functional
recovery were observed among this cohort. Consistent with our results, other researchers
have reported positive association of PAI with reduced pain and effective motor function
compared to other pain management approaches [45, 218-220]. Toftdahl et al [127]
compared early functional benefits of PAI compared to FNB and reported more patients
in the PAI group could walk greater than 3 meters on the day of surgery. In contrast,
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Tanikawa et al [133] found that FNB with SNB was more effective than PAI in reducing
pain within 3 hours after TKA, but less effective than PAI at 24 hours. The authors
speculate that PAI may have had a longer acting time because, while SNB was performed
prior to surgery, PAI was administered during surgery and may not have taken immediate
effect. Jian et al’s [221] meta-analysis results indicated equivalence of analgesic effect
between SNB and PAI groups at 24 hours. Chaubey et al [222] determined that FNB
provided better pain relief but reduced range of motion, while Carli et al [223] concluded
that FNB provided improved recovery initially and at 6 weeks. Beebe et al [41] reported
that FNB did not prevent early ambulation, and several studies agreed that FNB and PAI
had comparable pain intensity and effect on mobilization [50, 224-226].
Contrary to common concerns, occurrence of inpatient falls did not differ
significantly between the 2 groups, although 6 patients (1.2%) in the FNB group fell after
TKA compared with 2 in the PAI group (0.4%). Similarly in another study, 3 of 79
patients (4%) with FNB combined with SNB fell after TKA compared with 1 fall in 81
patients (1%) in the PAI group, but differences were not statistically significant [50]. We
previously reported a higher number of surgical site infections in the PAI group; these
patients were more likely to be readmitted (2 of 4), have revisions (3 of 4), and were
more expensive cases (above the average mean), both during the hospitalization and
follow-up. Iwakiri et al [227] studied 106 TKA patients who received PAI with or
without morphine and did not detect any infection cases. Further reports found no
differences in the rate of adverse events between FNB and PAI groups, and none of the
adverse events were directly related to analgesic approach [121, 129, 133, 219, 228].
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In terms of hospital LOS, we found a significant decrease in duration of stay
among patients in the PAI group. In an earlier report by Dalury [229], the mean hospital
LOS among patients who received PAI was 1.2 days, with most patients being discharged
home within 24 hours, and all by 48 hours. Similarly, Broome and Burnikel [230] found a
decrease in LOS from 60 hours to 53 hours when PAI was used compared to FNB. Yet,
contradicting results in the literature do exist, indicating no differences between FNB
with or without SNB or PAI in reducing hospital LOS [133, 136, 223, 225, 231].
As might be anticipated from the low pain scores reported in the PAI group,
patients also reported higher satisfaction with pain control compared to patients who
received FNB. However, while PAI patients had improved pain experience, no significant
differences were noted in overall satisfaction. Our patient satisfaction metrics were
collected after discharge, and so, are subject to recall bias; yet, it was interesting to find a
remarkably high satisfaction with pain control in the postdischarge period in both groups.
Apfelbaum et al [232] reported more patients experience pain after discharge than before,
and Lostak et al [233] demonstrated that the rate of satisfaction is high shortly after
surgery, but declines gradually thereafter. According to the literature, patient
dissatisfaction with pain after TKA is very common, ranging from 7.5% to 28.3%, while
our PAI group only had a 7.3% dissatisfaction rate [234, 235]. With many research
efforts conducted to seek early pain control and improved patient satisfaction, using PAI
continues to be an effective option [123].
Our study found evidence of significant savings when pain was managed using
PAI (P<.01). The standardized cost of analgesic approach materials (i.e., medications and
supplies) was 2.6 times higher for FNB compared to PAI; ($1,900 [$664] vs $713 [$150],
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respectively). In addition, the cost of pain medications was 1.4 times higher for FNB
patients, suggesting that using PAI may be possible to decrease the consumption of
opioids among patients. However, decisions about cost-effectiveness need to be based on
the entire cost of the episode rather than type of services; thus, our study concludes that
each patient who had their pain managed using PAI of ropivacaine, epinephrine,
ketorolac, and morphine saved approximately $3,539 on their total TKA hospitalization
(P<.01). This lower total cost is not strictly due to earlier discharges, as our calculation of
cost per type of service showed lower costs across majority of services. We observed no
significant differences the total cost of the 90-day follow-up period after discharge,
suggesting that savings from post-surgical pain management approach during the
hospitalization episode are not offset with higher follow-up costs.
Among other studies that used nonstandardized costing methods, the cost of PAI
with liposomal bupivacaine was $285, compared to the cost of FNB, which was $640
[230]. Dalury et al [229] estimated the cost of PAI with ropivacaine, epinephrine,
ketorolac, and clonidine as $46, and Corman et al [236] estimated cost of PAI with
bupivacaine, morphine, methylprednisolone, and cefuroxime as low as $16. The latter
study also estimated the cost of PAI with bupivacaine liposome as $319 and of
continuous peripheral nerve block with ropivacaine as $757.
It is important to point out that the mixed conclusions regarding PAI efficacy and
cost may be driven by differences in PAI mixture and methodology [212, 237]. Currently,
little scientific data exist to define guidelines for the most effective medication
combination or pain management protocol [122, 228, 229, 238, 239]. Therefore, use of
different PAI medication combinations (ie, medication type and volume) adds to the
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variability in cost across studies. The injection administration technique may also vary
among surgeons, and few studies provide clear descriptions of their administration
technique. Broome [49] demonstrated that using a small needle, such as 22-gauge instead
of 18-gauge, and infiltrating small amounts in a large number of locations provides better
efficacy. Dalury [229] recommended the use of control syringes, which allow for
aspiration before injection and are more comfortable for a surgeon’s hand. More studies
may be needed to identify the best PAI approach before final conclusions are made on
cost-effective pain management approaches.
Our study is limited by a retrospective, single-institution design using consecutive
patients at 2 exclusive, yet consecutive, time periods. The pain control protocol transition
from FNB with SNB to PAI was the only change introduced in the study time periods,
patient cohorts were clinically similar, and the same surgeons performed the operations.
Furthermore, our EHR did not contain detailed information on the progress of
rehabilitation; thus, our mobility measures were limited to the in-hospital phase, yet these
data are important to report as short-term mobility indicators. Additionally, patient selfreported pain scores often have great disparity due to variability in tolerance of pain. Still,
electronically-documented pain scores in the EHR, a major study asset, ensured accuracy,
synchronous collection and easy data retrieval for this large patient cohort. Conclusions
regarding patient satisfaction with pain control are limited due to the smaller sample size,
a consequence of the randomized nature of HCAHPS collection, but no other satisfaction
measures were readily available. While regression analyses were applied to demonstrate
associations adjusted for potential covariates, causation cannot be proven. Finally, our
cost analysis relied upon administrative claims data from our institution and we were
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unaware about post-care consumed elsewhere. Our calculation of cost in the follow-up
period was limited to local patients, who were more likely to have follow-up services
performed at our institution. Despite these limitations, the study uncovered differences
between 2 well established pain management approaches used for TKA in nearly 1,000
patients. Our unique ability to combine patient clinical data from medical records with
administration billing data, categorizing all line item services according to type into
related categories, and then applying cost standardization instead of nominal charges,
provides valuable information for policy makers and clinicians who are interested in
measuring value in health care. To our knowledge, this is the first study to examine
detailed cost per services between PAI and FNB with single-shot SNB for primary TKA.
CONCLUSIONS
The replacement of FNB with PAI led to improvements in hospital value metrics,
including early pain relief, recovery, LOS, patient satisfaction with pain, and total
hospitalization cost. Our findings provide valuable insight for clinicians and
policymakers to determine the most efficient and cost-effective pain management
approach after TKA, and can promote evidence-based clinical policy for cost-effective
pain management in orthopedic care. It is suggested to improve and expand the use of
PAI, but with caution in relation to possible infections or increased postdischarge cost.
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Figure 5.1 Flow Diagram of Patient Exclusions and Eligibility.
FNB indicates femoral nerve block; LOS, length of stay; NB, nerve block; PAI,
periarticular anesthetic injection; SNB, sciatic nerve block; and TKA, total knee
arthroplasty.
*Exclusion criteria in the 90-day follow-up period are not mutually exclusive.
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Figure 5.2 Comparison of Hospitalization Cost Per Service Between FNB and PAI.
FNB indicates femoral nerve block; OR, operating room; and PAI, periarticular anesthetic injection.
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Table 5.1 Sample Baseline Characteristics By Pain Management Approach
Characteristics

Total Sample,

FNB, No. (%)

PAI, No. (%)

P Value

No. (%) N=990

n=511

n=479

68.0 (9.4)

68.2 (9.3)

67.7 (9.6)

0.52a

≤ 54

67 (6.8)

35 (6.8)

32 (6.7)

0.77b

55-64

285 (28.8)

140 (27.4)

145 (30.3)

65-74

402 (40.6)

214 (41.9)

188 (39.2)

≥ 75

236 (23.8)

122 (23.9)

114 (23.8)

Normal (18.5-24.9)

141 (14.2)

79 (15.4)

62 (12.9)

Overweight (25.0-29.9)

315 (31.8)

166 (32.4)

149 (31.1)

Obese (≥ 30.0)

534 (54.0)

266 (52.2)

268 (56.0)

Female

609 (61.5)

328 (64.2)

281 (58.7)

Male

381 (38.5)

183 (35.8)

198 (41.3)

58 (6.0)

25 (5.0)

33 (7.0)

White

885 (89.3)

456 (89.2)

429 (89.5)

Other

47 (4.7)

30 (5.8)

17 (3.5)

Married

733 (74.0)

377 (73.8)

356 (74.3)

Single/divorced/widow

257 (26.0)

134 (26.2)

123 (25.7)

Age, y
Mean (SD)

BMI
0.46b

Sex
0.07b

Race
African American

0.37b

Marital status
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0.85b

Employment status
0.25b

Employed

240 (30.7)

112 (28.6)

128 (32.8)

Retired

422 (54.0)

223 (56.9)

199 (51.0)

Not employed/disabled

120 (15.3)

57 (14.5)

63 (16.2)

Local (Jax area)

565 (57.1)

276 (54.0)

289 (60.3)

Regional (120-mile)

276 (27.9)

151 (29.5)

125 (26.1)

Distant

149 (15.1)

84 (16.4)

65 (13.6)

353 (35.7)

171 (33.5)

182 (38.0)

637 (64.3)

340 (66.5)

297 (62.0)

Ever (current or former)

469 (47.4)

229 (44.8)

240 (50.1)

Never

521 (52.6)

282 (55.2)

239 (49.9)

Normal healthy person

10 (1.0)

7 (1.4)

3 (0.6)

Mild systematic disease

464 (46.9)

219 (42.9)

245 (51.1)

Severe systematic dis.

516 (52.1)

285 (55.8)

231 (48.2)

Weighted, mean (SD)

0.6 (1.2)

0.7 (1.2)

0.6 (1.1)

0.22a

Age-weighted, mean

3.0 (1.6)

3.1 (1.6)

2.9 (1.6)

0.19a

Area of residence
0.13b

(national/international)
Payer type
Nongovernment

0.14b

insurance
Government insurance
Tobacco use
0.10b

ASA scorec
0.02b

CCI

(SD)
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Comorbidityd
0.16b

0

547 (55.3)

270 (52.8)

277 (57.8)

1-2

359 (36.3)

190 (37.2)

169 (35.3)

≥3

84 (8.5)

51 (10.0)

33 (6.9)

Hypertension

254 (25.7)

152 (29.7)

102 (21.3)

<0.01b

Diabetes

101 (10.2)

56 (11.0)

45 (9.4)

0.46b

Peripheral vascular

65 (6.6)

42 (8.2)

23 (4.8)

0.04b

Cancer

64 (6.5)

33 (6.5)

31 (6.5)

>0.99b

Chronic pulmonary

60 (6.1)

35 (6.8)

25 (5.2)

0.30b

Anxiety/depression

43 (4.3)

17 (3.3)

26 (5.4)

0.12b

987 (99.7)

509 (99.6)

478 (99.8)

0.60b

96.1 (21.5)

96.0 (22.8)

96.2 (20.3)

0.84b

150.2 (25.7)

149.9 (26.9)

150.5 (24.3)

0.62b

Top comorbid conditionse

Elective admission
Elective
Surgery time, m
Mean (SD)
Anesthesia time, m
Mean (SD)

Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index;
CCI, Charlson Comorbidity Index; FNB, femoral nerve block; PAI, periarticular
anesthetic injection.
a
Wilcoxon signed rank test
b
Univariate χ2 test
c
ASA score
d
Comorbidity includes the number of conditions in CCI in addition to:
depression/anxiety, hypertension, and stroke
e
Comorbid conditions are not mutually exclusive as a patient may have more than 1
comorbidity diagnosis
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Table 5.2 Comparison of Outcomes Between FNB and PAI Groups
FNB
(n=511)

PAI
(n=479)

P
Value

At 24 hours

2.8 (1.7)

2.2 (1.5)

<0.01a

At 48 hours

3.1 (1.6)

3.1 (1.7)

0.68b

3.5 (1.4)

4.4 (1.6)

<0.01a

4.0 (3.0,

4.0 (3.0,

4.0)

5.0)

(3.0-9.0)

(3.0-15.0)

Walked during first 24 h postoperatively, No. (%)

4 (0.8)

33 (6.8)

<0.01b

Walked during 24-48 h postoperatively, No. (%)

494 (96.7)

477 (99.6)

0.01c

Distance walked in first 3 PT sessions, mean (SD), m

48.0 (67.0)

86.5 (82.2)

<0.01a

Time to first ambulation, mean (SD), h

31.3 (13.3)

22.3 (9.0)

<0.01a

In-hospital falls, No. (%)

6 (1.2)

2 (0.4)

0.29b

Surgical site infections

0 (0.0)

4 (0.8)

0.05b

3.6 (1.2)

3.8 (4.7)

0.40a

mean (SD), h

76.3 (15.9)

62.2 (20.7)

<0.01a

mean (SD), d

2.9 (0.7)

2.3 (0.9)

<0.01a

mean (SD), h

71.2 (15.9)

56.8 (20.0)

<0.01a

mean (SD), d

2.9 (0.7)

2.3 (0.8)

<0.01a

Outcomes
Pain scores, mean (SD)

Functional recovery
PT sessions received by patients, mean (SD)
Median (IQR)

Range

Length of stay
Time from admission to surgery, mean (SD), h
Time from admission to discharge

Time from end of surgery to discharge
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Discharge dispositiond
Home/home health, No. (%)

248 (48.2)

382 (79.3)

<0.01c

Other facility, No. (%)

266 (51.8)

100 (20.7)

<0.01c

Emergency visit within 14 days, No. (%)

19 (3.7)

19 (3.9)

0.87b

Readmission within 30 days, No. (%)

9 (1.8)

10 (2.1)

0.82b

Revision within 90 days, No. (%)

1 (0.2)

3 (0.6)

0.36b

Postdischarge

Abbreviations: FNB, femoral nerve block; PAI, periarticular anesthetic injection; POD,
postoperative day; PT, physical therapy.
a
Wilcoxon signed rank test
b
Fisher exact test
c
Univariate χ2 test
d
Inpatient mortality was 0 in both groups
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Table 5.3 Comparison of Patient Satisfaction Between FNB and PAI Groups
FNB

PAI

(n=158)b

(n=199)b

88.4 (18.4)

92.7 (16.8)

0.01c

95.3 (12.8)

98.5 (8.5)

<0.01c

96.6 (8.1)

97.4 (6.5)

0.54c

Questionsa

P Value

How often was your pain well controlled?
How often did the hospital staff do everything
they could to help you with your pain?
Your overall rating of the hospital stay

Abbreviations: FNB, femoral nerve block; PAI, periarticular anesthetic injection.
a
Satisfaction survey was distributed to a random sample of discharges (FNB=158
patients, PAI=199 patients).
b
Values expressed as mean (SD).
c
Wilcoxon signed rank test.
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Table 5.4 Comparison of Hospitalization Cost Between FNB and PAI Groups
Servicesa

Groups

Mean (SD)

Median

IQR

P

Analgesic

FNB

2,273.9 (673.5)

2,546.3

1,717.2, 2,674.2

<0.01b

approach

PAI

1,087.6 (177.9)

1,063.7

968.0, 1,188.5

Pain

FNB

238.0 (148.3)

235.0

107.0, 316.9

medications

PAI

160.3 (103.3)

138.7

79.3, 208.9

Room and

FNB

3,820.3 (1,192.9)

3,972.6

3,069.7, 4,153.2

board

PAI

2,739.5 (1,277.2)

2,437.7

1,805.7, 3,340.6

OR

FNB

3,226.8 (556.5)

3,189.5

2,865.4, 3,488.8

and recovery

PAI

3,037.9 (497.4)

2,996.3

2,705.3, 3,285.8

Orthopedic

FNB

1,901.0 (790.2)

1,400.3

1,400.3, 1,624.4

procedure

PAI

1,564.0 (345.1)

1,400.3

1,400.3, 1,624.4

Supplies

FNB

2,040.5 (718.9)

2,070.6

1,599.6, 2,316.7

PAI

2,035.6 (875.1)

2,041.9

1,577.5, 2,256.4

Physical

FNB

622.9 (172.7)

601.1

518.9, 686.7

therapy

PAI

496.9 (177.7)

468.2

386.4, 573.5

Other costs

FNB

1,792.4 (582.5)

1,634.2

1,497.4, 1,863.0

PAI

1,255.7 (1,519.0)

1,025.1

884.6, 1,249.3

Total cost in

FNB

15,541.9 (2,463.7)

15,090.3

14,202.0, 16,415.9

2016 $US

PAI

12,002.8 (3,079.5)

11,375.9

10,455.0, 12,559.7

<0.01b

<0.01b

<0.01b

0.02b

0.09b

<0.01b

<0.01b

<0.01b

Abbreviations: FNB, femoral nerve block; IQR, interquartile range; OR, operating room;
PAI, periarticular anesthetic injection; TKA, total knee arthroplasty.
a
Categories of services: (1) analgesic approach, including nerve block and periarticular
supplies and medications; (2) pain medications; (3) room and board, including
observation and intensive care unit room and board; (4) OR and recovery; (5) orthopedic
procedure; (6) supplies, including prostheses and nonprosthesis; (7) physical therapy; (8)
laboratory and pathology; and (9) other costs, including blood transfusion, other
medications/intravenous fluids, and miscellaneous. bWilcoxon signed rank test.
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Table 5.5 Comparison of 90-day Postdischargea Care Costs Between FNB and PAI
Servicesb
Evaluation & manag.

Room and board

OR and recovery

Orthopedic procedure

Pain medications

Other pharma.

Lab and Pathology

Supplies

Physical therapy

Other costs

Group

Mean (SD)

Median

Ranged

P

FNB

204.2 (342.2)

73.4

(0.0-2,725.7)

0.52c

PAI

220.7 (348.0)

90.2

(0.0-2,522.7)

FNB

137.7 (795.4)

0.0

(0.0-7,854.9)

PAI

173.7 (862.6)

0.0

(0.0-6,828.5)

FNB

73.1 (423.7)

0.0

(0.0-5,901.4)

PAI

57.9 (329.1)

0.0

(0.0-3,025.6)

FNB

15.3 (133.2)

0.0

(0.0-1,961.2)

PAI

26.4 (177.9)

0.0

(0.0-2,584.5)

FNB

45.5 (211.1)

0.0

(0.0-2,284.1)

PAI

39.7 (247.2)

0.0

(0.0-3,550.3)

FNB

85.7 (726.7)

0.0

(0.0-10,992.6) 0.44c

PAI

62.5 (442.6)

0.0

(0.0-5,775.9)

FNB

23.2 (93.3)

0.0

(0.0-695.2)

PAI

29.3 (102.4)

0.0

(0.0-719.9)

FNB

14.0 (59.2)

0.0

(0.0-404.2)

PAI

25.4 (141.3)

0.0

(0.0-1,457.5)

FNB

13.9 (77.1)

0.0

(0.0-795.5)

PAI

12.1 (62.0)

0.0

(0.0-518.9)

FNB

459.7 (897.5)

122.8

(0.0-7,921.8)

PAI

584.1 (1,337.4)

148.4

(0.0-15,214.1)
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0.64c

0.48c

0.01c

0.21c

0.42c

0.47c

0.96c

0.21c

Total cost inflated to

FNB

1,078.1 (2,314.5)

258.5

(0.0-16,302.2) 0.39c

2016 US dollars

PAI

1,236.1 (2,513.1)

317.9

(0.0-16,868.5)

Abbreviations: FNB, femoral nerve block; PAI, periarticular anesthetic injection; OR,
operating room.
a
90-day postdischarge cost was calculated for 263 FNB patients and 278 PAI patients.
Refer to the list of exclusion criteria in Figure 1.
b
Categories of services: (1) evaluation and management; (2) room and board, including
observation and intensive care unit room and board; (3) OR and recovery; (4) orthopedic
procedure; (5) pain medications; (6) other pharmaceuticals, including intravenous; (7)
laboratory and pathology; (8) supplies, including prostheses and nonprosthesis; (9)
physical therapy; and (10) other costs, including blood transfusion and miscellaneous.
c
Wilcoxon signed rank test.
d
Interquartile range was 0.00-0.00 for most categories; thus, range was reported to
provide better information about spread of cost. IQR for total cost was [FNB (51.1,
1,072) and PAI (39.4, 1,245.4)].
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Table 5.6 Linear Regression Analysis of Predictors of Selected Outcomes in TKA
Dependent Variables

Distance Walkedb

Postoperative LOSc

Pain Scores

Pain Scores

Time to First

(at 24 hours)

(at 48 hours)

Ambulationa

β

P Value

β

P Value

β

P Value

β

P Value

β

P Value

β

P Value

2.08

<0.01

2.24

<0.01

29.05

<0.01

93.85

<0.01

67.37

<0.01

9.60

<0.01

PAI

-0.55

<0.01

0.08

0.38

-8.86

<0.01

34.48

<0.01

-13.73

<0.01

-0.26

<0.01

≤ 54

0.93

<0.01

1.01

<0.01

-0.80

0.61

11.61

0.21

-3.42

0.15

0.05

0.03

55-64

0.26

0.03

0.39

<0.01

-0.48

0.59

12.64

0.02

-2.55

0.06

0.02

0.20

-0.37

<0.01

-0.36

<0.01

1.44

0.14

-11.49

0.05

3.81

0.01

-0.02

0.18

0.44

<0.01

0.47

<0.01

1.70

0.02

-41.82

<0.01

5.43

<0.01

0.02

0.12

African American

-0.02

0.93

0.04

0.85

-1.52

0.34

-0.38

0.96

-0.29

0.90

0.04

0.10

Other

-0.10

0.74

-0.54

0.08

-1.28

0.56

51.64

<0.01

-2.65

0.45

-0.05

0.15

Intercept

Total Cost Index
(Transformed Log)

Approach
FNB (reference)

Age

100

65-74 (reference)
≥ 75
Sex
Male (reference)
Female
Race
White (reference)

Marital Status
Not married (reference)
Married

0.03

0.79

0.09

0.44

-1.11

0.20

0.22

0.96

-3.62

<0.01

-

-

0.18

0.08

0.13

0.21

0.75

0.33

-20.77

<0.01

0.95

0.41

0.02

0.08

1-2

0.20

0.05

0.24

0.02

0.53

0.50

-3.02

0.53

1.80

0.12

-0.03

0.65

≥3

0.45

0.01

0.44

0.01

-0.34

0.80

-11.82

0.16

3.41

0.10

0.05

0.02

0.26

0.01

0.38

<0.01

2.75

<0.01

-15.63

<0.01

2.78

0.02

0.04

<.01

Obesity (BMI ≥ 30 kg/m2)
No (reference)
Yes
Comorbidity
0 (reference)
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ASA
Normal or mild
(reference)
Severe

Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; FNB, femoral nerve block; LOS, length of stay;
PAI, periarticular anesthetic injection; TKA, total knee arthroplasty.
a
Hours from end of surgery to first walk.
b
Meters walked in first 3 physical therapy sessions after surgery.
c
Hours from end of surgery to discharge.
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